GSE53960: rat RNA-Seq transcriptomic Bodymap
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Stat5a
|
ENSRNOG00000019496 | signal transducer and activator of transcription 5A |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Stat5a | rn6_v1_chr10_+_88764732_88764732 | -0.20 | 4.1e-04 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr4_+_70776046 | 44.33 |
ENSRNOT00000040403
|
Prss1
|
protease, serine 1 |
chr16_+_6970342 | 44.27 |
ENSRNOT00000061294
ENSRNOT00000048344 |
Itih4
|
inter-alpha-trypsin inhibitor heavy chain family, member 4 |
chr2_+_54466280 | 43.66 |
ENSRNOT00000033112
|
C6
|
complement C6 |
chr16_+_54164431 | 41.88 |
ENSRNOT00000090763
|
Fgl1
|
fibrinogen-like 1 |
chr2_+_181987217 | 31.44 |
ENSRNOT00000034521
|
Fgg
|
fibrinogen gamma chain |
chr2_+_104744461 | 31.04 |
ENSRNOT00000016083
ENSRNOT00000082627 |
Cp
|
ceruloplasmin |
chr3_-_63836017 | 30.86 |
ENSRNOT00000030978
|
AABR07052585.1
|
|
chr13_-_47397890 | 30.21 |
ENSRNOT00000005505
|
C4bpb
|
complement component 4 binding protein, beta |
chr5_-_77492013 | 30.08 |
ENSRNOT00000012293
|
LOC259245
|
alpha-2u globulin PGCL5 |
chr8_-_52937972 | 30.00 |
ENSRNOT00000007789
|
Nnmt
|
nicotinamide N-methyltransferase |
chr4_+_70689737 | 26.51 |
ENSRNOT00000018852
|
Prss2
|
protease, serine, 2 |
chr2_+_147496229 | 26.32 |
ENSRNOT00000022105
|
Tm4sf4
|
transmembrane 4 L six family member 4 |
chr1_+_229030233 | 26.31 |
ENSRNOT00000084503
|
Glyatl1
|
glycine-N-acyltransferase-like 1 |
chr8_-_111777602 | 26.11 |
ENSRNOT00000052317
ENSRNOT00000083855 |
RGD1310507
|
similar to RIKEN cDNA 1300017J02 |
chr4_-_23122725 | 23.95 |
ENSRNOT00000089086
|
Steap4
|
STEAP4 metalloreductase |
chr4_+_109497962 | 23.17 |
ENSRNOT00000057869
|
Reg1a
|
regenerating family member 1 alpha |
chr6_-_128003418 | 23.10 |
ENSRNOT00000013896
|
Serpina3c
|
serine (or cysteine) proteinase inhibitor, clade A, member 3C |
chr4_-_161850875 | 22.76 |
ENSRNOT00000009467
|
Pzp
|
pregnancy-zone protein |
chr6_-_127656603 | 22.37 |
ENSRNOT00000015516
|
Serpina11
|
serpin family A member 11 |
chr4_+_163162211 | 22.13 |
ENSRNOT00000082537
|
Clec1b
|
C-type lectin domain family 1, member B |
chr1_-_76780230 | 22.06 |
ENSRNOT00000002046
|
LOC100912485
|
alcohol sulfotransferase-like |
chr10_-_98544447 | 22.02 |
ENSRNOT00000073149
|
Abca6
|
ATP binding cassette subfamily A member 6 |
chrX_-_64800435 | 21.96 |
ENSRNOT00000005663
|
Asb12
|
ankyrin repeat and SOCS box-containing 12 |
chr2_+_55775274 | 21.79 |
ENSRNOT00000018545
|
C9
|
complement C9 |
chr3_-_55587946 | 21.72 |
ENSRNOT00000075107
|
Abcb11
|
ATP binding cassette subfamily B member 11 |
chr4_-_78879294 | 21.38 |
ENSRNOT00000084543
|
Igf2bp3
|
insulin-like growth factor 2 mRNA binding protein 3 |
chr9_+_100285804 | 21.07 |
ENSRNOT00000079305
|
Agxt
|
alanine-glyoxylate aminotransferase |
chr3_-_63568464 | 21.06 |
ENSRNOT00000068494
|
AABR07052585.2
|
|
chr1_+_83744238 | 20.71 |
ENSRNOT00000028249
|
Cyp2a1
|
cytochrome P450, family 2, subfamily a, polypeptide 1 |
chr6_+_127927650 | 20.55 |
ENSRNOT00000057271
|
LOC100909605
|
serine protease inhibitor A3F-like |
chr4_+_154215250 | 20.10 |
ENSRNOT00000072465
|
Mug2
|
murinoglobulin 2 |
chr5_-_52767592 | 20.07 |
ENSRNOT00000048383
|
LOC298111
|
alpha2u globulin |
chr15_-_46432965 | 20.05 |
ENSRNOT00000014320
|
Gata4
|
GATA binding protein 4 |
chr10_+_65767930 | 19.39 |
ENSRNOT00000039954
|
Vtn
|
vitronectin |
chr2_-_180914940 | 19.36 |
ENSRNOT00000015732
|
Tdo2
|
tryptophan 2,3-dioxygenase |
chr2_+_182006242 | 19.35 |
ENSRNOT00000064091
|
Fga
|
fibrinogen alpha chain |
chr16_+_50152008 | 19.25 |
ENSRNOT00000019237
|
Klkb1
|
kallikrein B1 |
chr10_+_11240138 | 19.19 |
ENSRNOT00000048687
|
Srl
|
sarcalumenin |
chr2_+_104416972 | 18.96 |
ENSRNOT00000017125
|
Trim55
|
tripartite motif-containing 55 |
chr5_-_77408323 | 18.79 |
ENSRNOT00000046857
ENSRNOT00000046760 |
LOC259245
Mup4
|
alpha-2u globulin PGCL5 major urinary protein 4 |
chr2_-_105089659 | 18.76 |
ENSRNOT00000043381
|
Cpb1
|
carboxypeptidase B1 |
chr5_-_77248563 | 18.67 |
ENSRNOT00000052243
|
LOC259245
|
alpha-2u globulin PGCL5 |
chrX_-_65400298 | 18.59 |
ENSRNOT00000032121
|
Vsig4
|
V-set and immunoglobulin domain containing 4 |
chr19_+_15195565 | 18.59 |
ENSRNOT00000090865
ENSRNOT00000078874 |
Ces1d
|
carboxylesterase 1D |
chr16_+_18690246 | 18.57 |
ENSRNOT00000081484
|
Mat1a
|
methionine adenosyltransferase 1A |
chr19_+_15294248 | 18.20 |
ENSRNOT00000024622
|
Ces1f
|
carboxylesterase 1F |
chr10_+_109707962 | 17.97 |
ENSRNOT00000054962
ENSRNOT00000088898 |
Gcgr
|
glucagon receptor |
chr6_+_128048099 | 17.60 |
ENSRNOT00000084685
ENSRNOT00000087017 |
LOC500712
|
Ab1-233 |
chr1_+_213577122 | 17.29 |
ENSRNOT00000071925
|
RGD1309350
|
similar to transthyretin (4L369) |
chr14_+_17195014 | 17.28 |
ENSRNOT00000031667
|
Cxcl11
|
C-X-C motif chemokine ligand 11 |
chr9_-_65790347 | 17.23 |
ENSRNOT00000028506
|
AABR07067812.1
|
|
chr8_-_37450340 | 17.19 |
ENSRNOT00000072224
|
LOC100912405
|
urinary protein 3-like |
chr16_-_56900052 | 16.66 |
ENSRNOT00000017339
|
Msr1
|
macrophage scavenger receptor 1 |
chr19_-_43911057 | 16.56 |
ENSRNOT00000026017
|
Ctrb1
|
chymotrypsinogen B1 |
chr11_-_60819249 | 16.45 |
ENSRNOT00000043917
ENSRNOT00000042447 |
Cd200r1l
|
CD200 receptor 1-like |
chr8_-_132910905 | 16.17 |
ENSRNOT00000008630
|
Fyco1
|
FYVE and coiled-coil domain containing 1 |
chr1_-_259287684 | 16.08 |
ENSRNOT00000054724
|
Cyp2c22
|
cytochrome P450, family 2, subfamily c, polypeptide 22 |
chr11_-_64952687 | 16.01 |
ENSRNOT00000087892
|
Popdc2
|
popeye domain containing 2 |
chr11_-_81717521 | 15.64 |
ENSRNOT00000058422
|
Ahsg
|
alpha-2-HS-glycoprotein |
chr4_-_69196430 | 15.62 |
ENSRNOT00000017673
|
LOC312273
|
Trypsin V-A |
chr1_-_258877045 | 15.54 |
ENSRNOT00000071633
|
Cyp2c13
|
cytochrome P450, family 2, subfamily c, polypeptide 13 |
chr14_-_80973456 | 15.45 |
ENSRNOT00000013257
|
Hgfac
|
HGF activator |
chr2_+_248398917 | 15.44 |
ENSRNOT00000045855
|
Gbp1
|
guanylate binding protein 1 |
chr6_+_23337571 | 15.38 |
ENSRNOT00000011832
|
RGD1304963
|
similar to hypothetical protein MGC38716 |
chr5_-_77342299 | 15.37 |
ENSRNOT00000075994
|
RGD1566134
|
similar to alpha-2u-globulin |
chr9_+_53013413 | 15.36 |
ENSRNOT00000005313
|
Ankar
|
ankyrin and armadillo repeat containing |
chr2_-_210749991 | 14.98 |
ENSRNOT00000051261
ENSRNOT00000052403 |
Gstm6l
|
glutathione S-transferase, mu 6-like |
chr5_-_77316764 | 14.91 |
ENSRNOT00000071395
ENSRNOT00000076464 |
Mup4
|
major urinary protein 4 |
chr11_+_74057361 | 14.78 |
ENSRNOT00000048746
|
Cpn2
|
carboxypeptidase N subunit 2 |
chr6_-_127508452 | 14.77 |
ENSRNOT00000073709
|
LOC100909524
|
protein Z-dependent protease inhibitor-like |
chr4_-_23135354 | 14.64 |
ENSRNOT00000011432
|
Steap4
|
STEAP4 metalloreductase |
chr4_-_129619142 | 14.63 |
ENSRNOT00000047453
|
Lmod3
|
leiomodin 3 |
chr16_+_83358116 | 14.61 |
ENSRNOT00000031109
|
Rab20
|
RAB20, member RAS oncogene family |
chr13_-_56877611 | 14.43 |
ENSRNOT00000079040
ENSRNOT00000017195 |
Cfhr1
|
complement factor H-related 1 |
chr19_+_27404712 | 14.37 |
ENSRNOT00000023657
|
Mylk3
|
myosin light chain kinase 3 |
chr10_+_53818818 | 14.28 |
ENSRNOT00000057260
|
Myh8
|
myosin heavy chain 8 |
chr13_-_80862963 | 14.28 |
ENSRNOT00000004864
|
Fmo3
|
flavin containing monooxygenase 3 |
chr1_-_89369960 | 14.10 |
ENSRNOT00000028545
|
Hamp
|
hepcidin antimicrobial peptide |
chr8_-_77398156 | 14.08 |
ENSRNOT00000091858
ENSRNOT00000085349 ENSRNOT00000082763 |
Lipc
|
lipase C, hepatic type |
chr6_-_24676524 | 13.99 |
ENSRNOT00000047853
|
Capn13
|
calpain 13 |
chr1_+_201687758 | 13.92 |
ENSRNOT00000093308
|
Dmbt1
|
deleted in malignant brain tumors 1 |
chr1_-_73619356 | 13.89 |
ENSRNOT00000074352
|
Lilrb3
|
leukocyte immunoglobulin like receptor B3 |
chr4_+_109467272 | 13.75 |
ENSRNOT00000008212
|
Reg3b
|
regenerating family member 3 beta |
chr1_-_104157855 | 13.57 |
ENSRNOT00000019311
|
Csrp3
|
cysteine and glycine rich protein 3 |
chr2_+_92574038 | 13.54 |
ENSRNOT00000089422
|
tGap1
|
GTPase activating protein testicular GAP1 |
chr6_+_127946686 | 13.47 |
ENSRNOT00000082680
|
LOC500712
|
Ab1-233 |
chr8_+_2659865 | 13.30 |
ENSRNOT00000088553
ENSRNOT00000010243 |
Casp12
|
caspase 12 |
chr3_+_53563194 | 13.26 |
ENSRNOT00000048300
|
Xirp2
|
xin actin-binding repeat containing 2 |
chr4_-_78759408 | 13.15 |
ENSRNOT00000050994
|
Igf2bp3
|
insulin-like growth factor 2 mRNA binding protein 3 |
chr8_-_128711221 | 13.11 |
ENSRNOT00000055888
|
Xirp1
|
xin actin-binding repeat containing 1 |
chr4_-_30338679 | 13.08 |
ENSRNOT00000012050
|
Pon3
|
paraoxonase 3 |
chr1_+_64506735 | 13.01 |
ENSRNOT00000086331
|
Nlrp12
|
NLR family, pyrin domain containing 12 |
chr15_-_33629699 | 12.99 |
ENSRNOT00000023302
|
Myh6
|
myosin heavy chain 6 |
chr1_+_72882806 | 12.94 |
ENSRNOT00000024640
|
Tnni3
|
troponin I3, cardiac type |
chr5_-_19368431 | 12.90 |
ENSRNOT00000012819
|
Cyp7a1
|
cytochrome P450, family 7, subfamily a, polypeptide 1 |
chrX_+_143097525 | 12.86 |
ENSRNOT00000004559
|
F9
|
coagulation factor IX |
chr10_+_90085559 | 12.84 |
ENSRNOT00000028332
|
Nags
|
N-acetylglutamate synthase |
chr1_-_258766881 | 12.82 |
ENSRNOT00000015801
|
Cyp2c12
|
cytochrome P450, family 2, subfamily c, polypeptide 12 |
chr10_-_110274768 | 12.81 |
ENSRNOT00000054931
|
Sectm1a
|
secreted and transmembrane 1A |
chr4_-_70659252 | 12.65 |
ENSRNOT00000048049
|
Try10
|
trypsin 10 |
chr14_+_22517774 | 12.64 |
ENSRNOT00000047655
|
Ugt2b37
|
UDP-glucuronosyltransferase 2 family, member 37 |
chr1_+_277068761 | 12.60 |
ENSRNOT00000044183
ENSRNOT00000022382 |
Habp2
|
hyaluronan binding protein 2 |
chr17_-_417480 | 12.56 |
ENSRNOT00000023685
|
Fbp1
|
fructose-bisphosphatase 1 |
chr3_-_71295575 | 12.48 |
ENSRNOT00000040303
ENSRNOT00000083015 |
Zswim2
|
zinc finger, SWIM-type containing 2 |
chr2_-_182035032 | 12.46 |
ENSRNOT00000009813
|
Fgb
|
fibrinogen beta chain |
chr15_-_34392066 | 12.42 |
ENSRNOT00000027315
|
Tgm1
|
transglutaminase 1 |
chr1_+_189364288 | 12.35 |
ENSRNOT00000080338
|
Acsm1
|
acyl-CoA synthetase medium-chain family member 1 |
chr2_+_140708397 | 12.35 |
ENSRNOT00000088846
|
Mgst2
|
microsomal glutathione S-transferase 2 |
chr1_-_169334093 | 12.31 |
ENSRNOT00000032587
|
Ubqln3
|
ubiquilin 3 |
chr9_+_15582564 | 12.24 |
ENSRNOT00000020640
|
LOC100912849
|
uncharacterized LOC100912849 |
chr20_+_13778178 | 12.23 |
ENSRNOT00000058314
|
Gstt4
|
glutathione S-transferase, theta 4 |
chr1_+_189241593 | 12.06 |
ENSRNOT00000046025
|
Acsm5
|
acyl-CoA synthetase medium-chain family member 5 |
chr8_+_116857684 | 12.04 |
ENSRNOT00000026711
|
Mst1
|
macrophage stimulating 1 |
chr1_-_224389389 | 11.94 |
ENSRNOT00000077408
ENSRNOT00000050010 |
UST4r
|
integral membrane transport protein UST4r |
chrX_-_14220662 | 11.85 |
ENSRNOT00000045753
|
Srpx
|
sushi-repeat-containing protein, X-linked |
chr11_+_7422272 | 11.81 |
ENSRNOT00000075964
|
Gbe1
|
1,4-alpha-glucan branching enzyme 1 |
chr6_+_2216623 | 11.78 |
ENSRNOT00000008045
|
Rmdn2
|
regulator of microtubule dynamics 2 |
chr16_-_7026540 | 11.78 |
ENSRNOT00000051751
|
Itih1
|
inter-alpha trypsin inhibitor, heavy chain 1 |
chr4_+_70614524 | 11.74 |
ENSRNOT00000041100
|
Prss3
|
protease, serine 3 |
chr10_+_64952119 | 11.67 |
ENSRNOT00000012154
|
Pipox
|
pipecolic acid and sarcosine oxidase |
chr10_-_34221928 | 11.66 |
ENSRNOT00000045545
|
Irgm
|
immunity-related GTPase M |
chr1_+_72874583 | 11.51 |
ENSRNOT00000077719
|
Dnaaf3
|
dynein, axonemal, assembly factor 3 |
chr9_-_27452902 | 11.50 |
ENSRNOT00000018325
|
Gsta1
|
glutathione S-transferase alpha 1 |
chr11_+_62584959 | 11.48 |
ENSRNOT00000071065
|
Gramd1c
|
GRAM domain containing 1C |
chr13_+_75175254 | 11.46 |
ENSRNOT00000044008
|
Sec16b
|
SEC16 homolog B, endoplasmic reticulum export factor |
chrX_-_64726210 | 11.43 |
ENSRNOT00000076012
ENSRNOT00000086265 |
Asb12
|
ankyrin repeat and SOCS box-containing 12 |
chr14_+_20266891 | 11.42 |
ENSRNOT00000004174
|
Gc
|
group specific component |
chr7_-_118840634 | 11.32 |
ENSRNOT00000031568
|
Apol11a
|
apolipoprotein L 11a |
chr4_-_30556814 | 11.32 |
ENSRNOT00000012760
|
Pdk4
|
pyruvate dehydrogenase kinase 4 |
chr4_+_70755795 | 11.31 |
ENSRNOT00000043527
|
LOC683849
|
similar to Anionic trypsin II precursor (Pretrypsinogen II) |
chr3_-_37854561 | 11.27 |
ENSRNOT00000076095
|
Neb
|
nebulin |
chr7_+_28066635 | 11.17 |
ENSRNOT00000005844
|
Pah
|
phenylalanine hydroxylase |
chr13_-_56693968 | 11.17 |
ENSRNOT00000060160
|
AABR07021096.1
|
|
chr5_+_124476168 | 11.06 |
ENSRNOT00000077754
|
RGD1564074
|
similar to novel protein |
chr1_-_78180216 | 10.99 |
ENSRNOT00000071576
|
C5ar2
|
complement component 5a receptor 2 |
chr5_-_4975436 | 10.96 |
ENSRNOT00000062006
|
Xkr9
|
XK related 9 |
chr13_+_83721300 | 10.95 |
ENSRNOT00000082677
|
Adcy10
|
adenylate cyclase 10 (soluble) |
chr13_-_57080491 | 10.93 |
ENSRNOT00000017749
ENSRNOT00000086572 ENSRNOT00000060111 |
Cfh
|
complement factor H |
chr1_+_213511874 | 10.93 |
ENSRNOT00000078080
ENSRNOT00000016883 |
Cyp2e1
|
cytochrome P450, family 2, subfamily e, polypeptide 1 |
chr2_-_93641497 | 10.83 |
ENSRNOT00000013720
|
Chmp4c
|
charged multivesicular body protein 4C |
chr9_+_95221474 | 10.83 |
ENSRNOT00000066839
|
Ugt1a5
|
UDP glucuronosyltransferase family 1 member A5 |
chr10_+_4951557 | 10.78 |
ENSRNOT00000003451
|
Prm3
|
protamine 3 |
chr20_+_26999795 | 10.75 |
ENSRNOT00000057872
|
Mypn
|
myopalladin |
chr13_+_83073544 | 10.74 |
ENSRNOT00000066119
ENSRNOT00000079796 ENSRNOT00000077070 |
Dpt
|
dermatopontin |
chr2_-_191294374 | 10.71 |
ENSRNOT00000067469
|
RGD1562234
|
similar to S100 calcium-binding protein, ventral prostate |
chr10_-_98469799 | 10.69 |
ENSRNOT00000087502
ENSRNOT00000088646 |
Abca9
|
ATP binding cassette subfamily A member 9 |
chr9_-_4327679 | 10.69 |
ENSRNOT00000073468
|
LOC100910235
|
sulfotransferase 1C1-like |
chr10_+_56662561 | 10.66 |
ENSRNOT00000025254
|
Asgr1
|
asialoglycoprotein receptor 1 |
chr14_+_22806132 | 10.60 |
ENSRNOT00000002728
|
Ugt2b10
|
UDP glucuronosyltransferase 2 family, polypeptide B10 |
chr16_-_19942343 | 10.53 |
ENSRNOT00000087162
ENSRNOT00000091906 |
Bst2
|
bone marrow stromal cell antigen 2 |
chr16_+_23317953 | 10.50 |
ENSRNOT00000075287
|
AABR07024972.1
|
|
chr16_+_74531564 | 10.48 |
ENSRNOT00000078971
|
Slc25a15
|
solute carrier family 25 member 15 |
chr9_+_14529218 | 10.48 |
ENSRNOT00000016893
|
Apobec2
|
apolipoprotein B mRNA editing enzyme catalytic subunit 2 |
chr7_-_117680004 | 10.47 |
ENSRNOT00000040422
|
Slc39a4
|
solute carrier family 39 member 4 |
chr15_+_42659371 | 10.45 |
ENSRNOT00000091612
|
Clu
|
clusterin |
chr16_-_20807070 | 10.42 |
ENSRNOT00000072536
|
Comp
|
cartilage oligomeric matrix protein |
chr3_+_95232166 | 10.40 |
ENSRNOT00000017952
|
LOC691083
|
hypothetical protein LOC691083 |
chr2_-_22147115 | 10.39 |
ENSRNOT00000017408
|
Spz1
|
spermatogenic leucine zipper 1 |
chr2_-_54823917 | 10.36 |
ENSRNOT00000039057
ENSRNOT00000079333 |
Card6
|
caspase recruitment domain family, member 6 |
chr9_-_43116521 | 10.31 |
ENSRNOT00000039437
|
Ankrd23
|
ankyrin repeat domain 23 |
chr9_+_95233957 | 10.28 |
ENSRNOT00000071003
|
Ugt1a5
|
UDP glucuronosyltransferase family 1 member A5 |
chr1_+_203160323 | 10.26 |
ENSRNOT00000027919
|
AABR07005844.1
|
|
chr13_+_83073866 | 10.25 |
ENSRNOT00000075996
|
Dpt
|
dermatopontin |
chr14_-_60276794 | 10.24 |
ENSRNOT00000048509
|
Slc34a2
|
solute carrier family 34 member 2 |
chr18_-_29562153 | 10.06 |
ENSRNOT00000023977
|
Cd14
|
CD14 molecule |
chr3_-_101474890 | 10.03 |
ENSRNOT00000091869
|
Bbox1
|
gamma-butyrobetaine hydroxylase 1 |
chr13_-_50499060 | 9.99 |
ENSRNOT00000065347
ENSRNOT00000076924 |
Etnk2
|
ethanolamine kinase 2 |
chr8_-_132911193 | 9.97 |
ENSRNOT00000087799
|
Fyco1
|
FYVE and coiled-coil domain containing 1 |
chr5_-_77433847 | 9.95 |
ENSRNOT00000076906
ENSRNOT00000043056 |
LOC500473
Mup4
|
similar to alpha-2u globulin PGCL2 major urinary protein 4 |
chr7_+_1206648 | 9.94 |
ENSRNOT00000073689
|
Pros1
|
protein S (alpha) |
chr2_+_87418517 | 9.93 |
ENSRNOT00000048046
|
LOC100909879
|
tyrosine-protein phosphatase non-receptor type substrate 1-like |
chr1_-_189359730 | 9.91 |
ENSRNOT00000066597
|
RGD1559600
|
RGD1559600 |
chr1_-_98493978 | 9.86 |
ENSRNOT00000023942
|
Nkg7
|
natural killer cell granule protein 7 |
chr20_-_4561062 | 9.78 |
ENSRNOT00000065044
ENSRNOT00000092698 ENSRNOT00000060607 |
Cfb
C2
|
complement factor B complement C2 |
chr2_-_60683451 | 9.75 |
ENSRNOT00000046215
|
Rai14
|
retinoic acid induced 14 |
chr6_+_56846789 | 9.63 |
ENSRNOT00000032108
|
Agmo
|
alkylglycerol monooxygenase |
chr8_-_54998864 | 9.62 |
ENSRNOT00000059191
|
Tex12
|
testis expressed 12 |
chr16_-_74963044 | 9.60 |
ENSRNOT00000018362
|
Ccdc70
|
coiled-coil domain containing 70 |
chr1_+_101502987 | 9.58 |
ENSRNOT00000085005
|
Tulp2
|
tubby-like protein 2 |
chrX_-_98095663 | 9.57 |
ENSRNOT00000004491
|
Rbm31y
|
RNA binding motif 31, Y-linked |
chr14_+_7113544 | 9.53 |
ENSRNOT00000038188
|
Hsd17b13
|
hydroxysteroid (17-beta) dehydrogenase 13 |
chr6_+_10642700 | 9.44 |
ENSRNOT00000040329
|
LOC100359600
|
karyopherin alpha 2-like |
chr14_+_22375955 | 9.43 |
ENSRNOT00000063915
ENSRNOT00000034784 |
Ugt2b37
|
UDP-glucuronosyltransferase 2 family, member 37 |
chr1_+_72784966 | 9.43 |
ENSRNOT00000090065
ENSRNOT00000041527 |
Tmem86b
|
transmembrane protein 86B |
chr1_-_169344306 | 9.40 |
ENSRNOT00000022852
|
Ubqlnl
|
ubiquilin-like |
chr13_+_75177965 | 9.39 |
ENSRNOT00000007321
|
Sec16b
|
SEC16 homolog B, endoplasmic reticulum export factor |
chr20_-_3793985 | 9.37 |
ENSRNOT00000049540
ENSRNOT00000086293 |
RT1-CE16
|
RT1 class I, locus CE16 |
chr11_+_61609370 | 9.37 |
ENSRNOT00000088880
ENSRNOT00000082533 |
Gramd1c
|
GRAM domain containing 1C |
chr3_+_79678201 | 9.33 |
ENSRNOT00000087604
ENSRNOT00000079709 |
Mtch2
|
mitochondrial carrier 2 |
chr17_-_69827112 | 9.28 |
ENSRNOT00000023835
|
Akr1c14
|
aldo-keto reductase family 1, member C14 |
chr1_+_264893162 | 9.28 |
ENSRNOT00000021714
|
Tlx1
|
T-cell leukemia, homeobox 1 |
chr7_-_140090922 | 9.27 |
ENSRNOT00000014456
|
Lalba
|
lactalbumin, alpha |
chr15_-_35394792 | 9.23 |
ENSRNOT00000028058
|
Gzmc
|
granzyme C |
chr13_-_91427575 | 9.21 |
ENSRNOT00000012092
|
Apcs
|
amyloid P component, serum |
chr1_-_73660593 | 9.19 |
ENSRNOT00000038802
|
Lilra5
|
leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 5 |
chr7_-_124999137 | 9.19 |
ENSRNOT00000039228
|
Pnpla5
|
patatin-like phospholipase domain containing 5 |
chr10_+_34277993 | 9.09 |
ENSRNOT00000055872
ENSRNOT00000003343 |
Ifi47
|
interferon gamma inducible protein 47 |
chr4_-_68349273 | 9.02 |
ENSRNOT00000016251
|
Prss37
|
protease, serine, 37 |
chr1_-_80594136 | 9.00 |
ENSRNOT00000024800
|
Apoc2
|
apolipoprotein C2 |
chr13_-_27653839 | 8.98 |
ENSRNOT00000071638
|
LOC100360575
|
signal-regulatory protein alpha-like |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
14.6 | 43.7 | GO:0001969 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
14.1 | 14.1 | GO:0034760 | negative regulation of iron ion transmembrane transport(GO:0034760) |
10.1 | 30.2 | GO:0045959 | negative regulation of complement activation, classical pathway(GO:0045959) |
8.4 | 25.2 | GO:1990869 | response to chemokine(GO:1990868) cellular response to chemokine(GO:1990869) |
7.0 | 21.1 | GO:0019265 | glycine biosynthetic process, by transamination of glyoxylate(GO:0019265) oxalic acid secretion(GO:0046724) |
6.7 | 20.1 | GO:0035054 | septum secundum development(GO:0003285) embryonic heart tube anterior/posterior pattern specification(GO:0035054) negative regulation of connective tissue replacement(GO:1905204) |
6.4 | 31.8 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
6.2 | 18.6 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
5.5 | 21.8 | GO:0046351 | disaccharide biosynthetic process(GO:0046351) |
5.3 | 16.0 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
5.1 | 5.1 | GO:0042853 | L-alanine catabolic process(GO:0042853) |
4.9 | 44.4 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
4.8 | 33.8 | GO:0009804 | coumarin metabolic process(GO:0009804) |
4.8 | 19.2 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
4.7 | 14.1 | GO:0010034 | response to acetate(GO:0010034) |
4.5 | 13.6 | GO:1903919 | regulation of actin filament severing(GO:1903918) negative regulation of actin filament severing(GO:1903919) |
4.5 | 13.5 | GO:0002876 | positive regulation of chronic inflammatory response to antigenic stimulus(GO:0002876) |
4.5 | 8.9 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
4.3 | 13.0 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
4.3 | 13.0 | GO:1905242 | response to 3,3',5-triiodo-L-thyronine(GO:1905242) cellular response to 3,3',5-triiodo-L-thyronine(GO:1905243) |
4.1 | 32.6 | GO:0097461 | ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
4.0 | 4.0 | GO:0010716 | negative regulation of extracellular matrix disassembly(GO:0010716) |
4.0 | 12.0 | GO:0001788 | antibody-dependent cellular cytotoxicity(GO:0001788) |
4.0 | 15.9 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
3.9 | 11.7 | GO:0019474 | lysine catabolic process(GO:0006554) L-lysine catabolic process to acetyl-CoA(GO:0019474) L-lysine catabolic process(GO:0019477) L-lysine metabolic process(GO:0046440) |
3.8 | 3.8 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
3.7 | 33.7 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
3.7 | 18.6 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
3.7 | 29.6 | GO:0015679 | plasma membrane copper ion transport(GO:0015679) |
3.7 | 11.0 | GO:0071623 | negative regulation of granulocyte chemotaxis(GO:0071623) negative regulation of neutrophil chemotaxis(GO:0090024) |
3.7 | 11.0 | GO:0006480 | N-terminal protein amino acid methylation(GO:0006480) |
3.6 | 18.1 | GO:0046087 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
3.5 | 24.8 | GO:1901098 | positive regulation of autophagosome maturation(GO:1901098) |
3.5 | 10.5 | GO:0002731 | negative regulation of dendritic cell cytokine production(GO:0002731) |
3.5 | 31.6 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
3.5 | 10.5 | GO:0034224 | cellular response to zinc ion starvation(GO:0034224) |
3.5 | 10.5 | GO:1902996 | regulation of neuronal signal transduction(GO:1902847) positive regulation of tau-protein kinase activity(GO:1902949) neurofibrillary tangle assembly(GO:1902988) regulation of neurofibrillary tangle assembly(GO:1902996) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
3.4 | 17.2 | GO:0006526 | arginine biosynthetic process(GO:0006526) |
3.4 | 13.8 | GO:1903576 | response to L-arginine(GO:1903576) |
3.2 | 9.6 | GO:0036102 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
3.2 | 6.4 | GO:2000259 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
3.1 | 6.3 | GO:0072719 | cellular response to cisplatin(GO:0072719) |
3.1 | 21.7 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
3.1 | 67.5 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
3.0 | 21.2 | GO:0019441 | tryptophan catabolic process to kynurenine(GO:0019441) |
3.0 | 9.0 | GO:0060697 | positive regulation of phospholipid catabolic process(GO:0060697) |
3.0 | 8.9 | GO:0060545 | positive regulation of necroptotic process(GO:0060545) |
3.0 | 14.8 | GO:0000066 | mitochondrial ornithine transport(GO:0000066) |
2.9 | 8.8 | GO:0035697 | CD8-positive, alpha-beta T cell extravasation(GO:0035697) |
2.9 | 8.7 | GO:0060764 | cell-cell signaling involved in mammary gland development(GO:0060764) |
2.9 | 69.1 | GO:0030574 | collagen catabolic process(GO:0030574) |
2.9 | 11.5 | GO:1904975 | response to bleomycin(GO:1904975) |
2.9 | 14.4 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
2.9 | 20.1 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
2.8 | 25.2 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
2.8 | 27.5 | GO:0046060 | dATP metabolic process(GO:0046060) |
2.8 | 19.3 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
2.7 | 8.2 | GO:0002434 | immune complex clearance(GO:0002434) |
2.7 | 8.2 | GO:0051012 | microtubule sliding(GO:0051012) |
2.7 | 21.4 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
2.6 | 10.6 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
2.6 | 5.2 | GO:0002488 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway(GO:0002488) antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent(GO:0002489) |
2.6 | 15.4 | GO:1900041 | negative regulation of interleukin-2 secretion(GO:1900041) |
2.5 | 14.9 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
2.5 | 5.0 | GO:2000502 | negative regulation of natural killer cell chemotaxis(GO:2000502) |
2.5 | 7.4 | GO:0046968 | cytosol to ER transport(GO:0046967) peptide antigen transport(GO:0046968) |
2.5 | 7.4 | GO:0014016 | neuroblast differentiation(GO:0014016) |
2.5 | 7.4 | GO:1903173 | phytol metabolic process(GO:0033306) fatty alcohol metabolic process(GO:1903173) |
2.4 | 14.7 | GO:0090383 | phagosome acidification(GO:0090383) |
2.4 | 14.5 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
2.4 | 14.5 | GO:0034059 | response to anoxia(GO:0034059) |
2.4 | 9.4 | GO:0071718 | sodium-independent icosanoid transport(GO:0071718) |
2.4 | 7.1 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
2.3 | 9.2 | GO:1903015 | regulation of exo-alpha-sialidase activity(GO:1903015) |
2.3 | 6.8 | GO:1901377 | toxin catabolic process(GO:0009407) mycotoxin catabolic process(GO:0043387) aflatoxin catabolic process(GO:0046223) secondary metabolite catabolic process(GO:0090487) organic heteropentacyclic compound catabolic process(GO:1901377) |
2.3 | 4.5 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
2.2 | 13.1 | GO:0035701 | hematopoietic stem cell migration(GO:0035701) |
2.2 | 2.2 | GO:0034140 | negative regulation of toll-like receptor 3 signaling pathway(GO:0034140) |
2.2 | 36.8 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
2.2 | 6.5 | GO:0055073 | cadmium ion homeostasis(GO:0055073) |
2.1 | 6.3 | GO:0002462 | tolerance induction to nonself antigen(GO:0002462) |
2.1 | 6.3 | GO:2000342 | negative regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000342) |
2.1 | 12.4 | GO:0010266 | response to vitamin B1(GO:0010266) |
2.1 | 10.3 | GO:0060297 | regulation of sarcomere organization(GO:0060297) |
2.1 | 6.2 | GO:0060468 | prevention of polyspermy(GO:0060468) |
2.0 | 6.1 | GO:1990743 | protein sialylation(GO:1990743) |
2.0 | 6.0 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
2.0 | 18.0 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
2.0 | 18.0 | GO:0048207 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
2.0 | 41.3 | GO:0035634 | response to stilbenoid(GO:0035634) |
1.9 | 15.4 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
1.9 | 5.7 | GO:0042222 | interleukin-1 biosynthetic process(GO:0042222) |
1.9 | 5.7 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
1.9 | 7.5 | GO:1901423 | response to benzene(GO:1901423) |
1.8 | 7.4 | GO:0044243 | multicellular organism catabolic process(GO:0044243) |
1.8 | 5.5 | GO:0019303 | D-ribose catabolic process(GO:0019303) |
1.8 | 12.6 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
1.8 | 8.9 | GO:0006642 | triglyceride mobilization(GO:0006642) |
1.8 | 7.1 | GO:0003257 | positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003257) notochord formation(GO:0014028) |
1.7 | 34.9 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
1.7 | 7.0 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
1.7 | 3.5 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
1.7 | 5.2 | GO:0006552 | leucine catabolic process(GO:0006552) |
1.7 | 5.2 | GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
1.7 | 5.2 | GO:2000384 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
1.7 | 8.6 | GO:0050828 | regulation of liquid surface tension(GO:0050828) |
1.7 | 5.1 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
1.7 | 6.7 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
1.7 | 3.3 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
1.7 | 11.6 | GO:0060763 | mammary duct terminal end bud growth(GO:0060763) |
1.6 | 6.6 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
1.6 | 3.2 | GO:1901143 | insulin catabolic process(GO:1901143) |
1.6 | 4.8 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
1.6 | 17.6 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
1.6 | 4.8 | GO:0019064 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
1.6 | 1.6 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
1.6 | 19.1 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
1.6 | 14.3 | GO:0030049 | muscle filament sliding(GO:0030049) |
1.6 | 45.5 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
1.6 | 6.2 | GO:0035552 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded DNA demethylation(GO:0035552) oxidative single-stranded RNA demethylation(GO:0035553) |
1.6 | 7.8 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
1.6 | 23.4 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
1.6 | 6.2 | GO:0034240 | negative regulation of macrophage fusion(GO:0034240) |
1.6 | 4.7 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
1.5 | 6.1 | GO:0071724 | response to diacyl bacterial lipopeptide(GO:0071724) cellular response to diacyl bacterial lipopeptide(GO:0071726) |
1.5 | 6.0 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
1.5 | 12.0 | GO:0006559 | L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
1.5 | 4.4 | GO:0051977 | lysophospholipid transport(GO:0051977) |
1.5 | 10.4 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
1.5 | 11.8 | GO:0001845 | phagolysosome assembly(GO:0001845) |
1.4 | 7.2 | GO:0070945 | neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
1.4 | 7.2 | GO:0000706 | meiotic DNA double-strand break processing(GO:0000706) |
1.4 | 2.9 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
1.4 | 12.9 | GO:0070857 | regulation of bile acid biosynthetic process(GO:0070857) |
1.4 | 2.8 | GO:0098759 | response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
1.4 | 15.6 | GO:0006068 | ethanol catabolic process(GO:0006068) |
1.4 | 4.3 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
1.4 | 4.2 | GO:0006214 | thymidine catabolic process(GO:0006214) pyrimidine deoxyribonucleoside catabolic process(GO:0046127) |
1.4 | 21.0 | GO:0015671 | oxygen transport(GO:0015671) |
1.4 | 18.2 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
1.4 | 5.6 | GO:0046013 | regulation of T cell homeostatic proliferation(GO:0046013) |
1.4 | 5.5 | GO:0018992 | germ-line sex determination(GO:0018992) |
1.4 | 5.5 | GO:0032827 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) |
1.4 | 9.7 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
1.4 | 5.5 | GO:0052314 | isoquinoline alkaloid metabolic process(GO:0033076) phytoalexin metabolic process(GO:0052314) |
1.4 | 9.6 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
1.4 | 13.6 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
1.4 | 5.4 | GO:0023021 | termination of signal transduction(GO:0023021) |
1.4 | 4.1 | GO:0048865 | stem cell fate commitment(GO:0048865) |
1.3 | 4.0 | GO:0032298 | positive regulation of DNA-dependent DNA replication initiation(GO:0032298) |
1.3 | 5.4 | GO:0015747 | urate transport(GO:0015747) |
1.3 | 17.3 | GO:0010818 | T cell chemotaxis(GO:0010818) |
1.3 | 6.6 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
1.3 | 3.9 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
1.3 | 9.2 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
1.3 | 3.9 | GO:0016062 | adaptation of rhodopsin mediated signaling(GO:0016062) light adaption(GO:0036367) |
1.3 | 3.9 | GO:0045575 | basophil activation(GO:0045575) |
1.3 | 6.5 | GO:0035627 | ceramide transport(GO:0035627) |
1.3 | 47.8 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
1.3 | 6.5 | GO:0060235 | lens induction in camera-type eye(GO:0060235) |
1.3 | 15.4 | GO:0033623 | regulation of integrin activation(GO:0033623) |
1.3 | 6.4 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
1.3 | 1.3 | GO:2000563 | positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
1.3 | 5.1 | GO:0050711 | negative regulation of interleukin-1 secretion(GO:0050711) |
1.3 | 2.5 | GO:0001802 | type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) |
1.3 | 7.6 | GO:0060481 | lobar bronchus epithelium development(GO:0060481) |
1.3 | 1.3 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
1.3 | 5.0 | GO:0060474 | positive regulation of sperm motility involved in capacitation(GO:0060474) |
1.3 | 8.8 | GO:0071415 | cellular response to purine-containing compound(GO:0071415) |
1.2 | 3.6 | GO:1902966 | regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
1.2 | 3.6 | GO:0031989 | bombesin receptor signaling pathway(GO:0031989) |
1.2 | 5.9 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
1.2 | 4.7 | GO:0030916 | otic vesicle formation(GO:0030916) |
1.2 | 4.7 | GO:0060178 | regulation of exocyst localization(GO:0060178) |
1.2 | 18.6 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
1.2 | 25.6 | GO:0030220 | platelet formation(GO:0030220) |
1.2 | 5.8 | GO:0030070 | insulin processing(GO:0030070) |
1.2 | 3.5 | GO:0006431 | methionyl-tRNA aminoacylation(GO:0006431) |
1.2 | 11.5 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
1.1 | 4.6 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
1.1 | 3.4 | GO:0006106 | fumarate metabolic process(GO:0006106) |
1.1 | 3.4 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
1.1 | 1.1 | GO:0060374 | mast cell differentiation(GO:0060374) regulation of mast cell differentiation(GO:0060375) |
1.1 | 2.2 | GO:1990418 | response to insulin-like growth factor stimulus(GO:1990418) |
1.1 | 12.3 | GO:2000257 | regulation of complement activation(GO:0030449) regulation of protein activation cascade(GO:2000257) |
1.1 | 16.6 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
1.1 | 9.9 | GO:0042730 | fibrinolysis(GO:0042730) |
1.1 | 1.1 | GO:1903972 | regulation of macrophage colony-stimulating factor signaling pathway(GO:1902226) regulation of response to macrophage colony-stimulating factor(GO:1903969) regulation of cellular response to macrophage colony-stimulating factor stimulus(GO:1903972) |
1.1 | 2.2 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
1.1 | 2.2 | GO:0015677 | copper ion import(GO:0015677) copper ion export(GO:0060003) |
1.1 | 5.4 | GO:0080154 | regulation of fertilization(GO:0080154) |
1.1 | 17.2 | GO:0009750 | response to fructose(GO:0009750) |
1.1 | 10.7 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
1.1 | 5.4 | GO:1902019 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
1.1 | 4.2 | GO:1902336 | positive regulation of retinal ganglion cell axon guidance(GO:1902336) |
1.0 | 5.2 | GO:2000435 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
1.0 | 4.2 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
1.0 | 2.1 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
1.0 | 3.1 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
1.0 | 5.2 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
1.0 | 3.1 | GO:2000620 | positive regulation of histone H4-K16 acetylation(GO:2000620) |
1.0 | 3.1 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
1.0 | 3.0 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
1.0 | 2.0 | GO:0010899 | regulation of phosphatidylcholine catabolic process(GO:0010899) |
1.0 | 3.9 | GO:1990375 | baculum development(GO:1990375) |
1.0 | 2.9 | GO:0014908 | myotube differentiation involved in skeletal muscle regeneration(GO:0014908) |
1.0 | 6.7 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
1.0 | 4.8 | GO:0045852 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
1.0 | 2.9 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.9 | 1.9 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
0.9 | 6.6 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.9 | 2.8 | GO:0018282 | metal incorporation into metallo-sulfur cluster(GO:0018282) iron incorporation into metallo-sulfur cluster(GO:0018283) |
0.9 | 9.3 | GO:0006086 | acetyl-CoA biosynthetic process from pyruvate(GO:0006086) |
0.9 | 23.2 | GO:0019835 | cytolysis(GO:0019835) |
0.9 | 2.8 | GO:1901367 | response to L-cysteine(GO:1901367) |
0.9 | 9.2 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.9 | 10.0 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.9 | 1.8 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.9 | 3.5 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.9 | 27.3 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.9 | 8.8 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.9 | 3.5 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.9 | 0.9 | GO:1903796 | negative regulation of inorganic anion transmembrane transport(GO:1903796) |
0.9 | 6.0 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
0.9 | 3.4 | GO:0044691 | tooth eruption(GO:0044691) |
0.9 | 6.9 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.9 | 23.0 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.9 | 8.5 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.8 | 2.5 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
0.8 | 2.5 | GO:1904953 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904953) canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904954) |
0.8 | 1.7 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.8 | 3.3 | GO:1990646 | cellular response to prolactin(GO:1990646) |
0.8 | 2.5 | GO:0032066 | nucleolus to nucleoplasm transport(GO:0032066) |
0.8 | 4.1 | GO:0007343 | egg activation(GO:0007343) |
0.8 | 2.4 | GO:0032621 | interleukin-18 production(GO:0032621) positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.8 | 5.7 | GO:0090232 | positive regulation of spindle checkpoint(GO:0090232) positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
0.8 | 3.2 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.8 | 3.2 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.8 | 4.0 | GO:0050748 | negative regulation of lipoprotein metabolic process(GO:0050748) |
0.8 | 2.4 | GO:0032696 | negative regulation of interleukin-13 production(GO:0032696) |
0.8 | 4.7 | GO:0032700 | negative regulation of interleukin-17 production(GO:0032700) |
0.8 | 1.6 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.8 | 3.1 | GO:0090290 | regulation of osteoclast proliferation(GO:0090289) positive regulation of osteoclast proliferation(GO:0090290) |
0.8 | 1.5 | GO:0072126 | positive regulation of glomerular mesangial cell proliferation(GO:0072126) |
0.8 | 14.7 | GO:1900004 | negative regulation of serine-type endopeptidase activity(GO:1900004) negative regulation of serine-type peptidase activity(GO:1902572) |
0.8 | 5.4 | GO:0003360 | brainstem development(GO:0003360) |
0.8 | 3.8 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.8 | 10.0 | GO:2000194 | regulation of female gonad development(GO:2000194) |
0.8 | 2.3 | GO:0010813 | neuropeptide catabolic process(GO:0010813) |
0.8 | 3.8 | GO:0045341 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
0.8 | 6.1 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.8 | 6.9 | GO:0086043 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.8 | 2.3 | GO:0042435 | indole-containing compound biosynthetic process(GO:0042435) |
0.7 | 5.2 | GO:0007144 | female meiosis I(GO:0007144) |
0.7 | 2.2 | GO:0035425 | autocrine signaling(GO:0035425) paracrine signaling(GO:0038001) |
0.7 | 3.7 | GO:0015793 | glycerol transport(GO:0015793) |
0.7 | 14.0 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.7 | 2.2 | GO:1901318 | negative regulation of sperm motility(GO:1901318) |
0.7 | 8.8 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
0.7 | 6.6 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
0.7 | 2.2 | GO:0009822 | lipid hydroxylation(GO:0002933) alkaloid catabolic process(GO:0009822) |
0.7 | 4.3 | GO:0070417 | cellular response to cold(GO:0070417) |
0.7 | 5.0 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.7 | 2.1 | GO:0032916 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) positive regulation of transforming growth factor beta3 production(GO:0032916) |
0.7 | 9.0 | GO:0097577 | intracellular sequestering of iron ion(GO:0006880) sequestering of iron ion(GO:0097577) |
0.7 | 4.1 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.7 | 6.1 | GO:0046549 | retinal cone cell development(GO:0046549) |
0.7 | 5.4 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.7 | 6.7 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.7 | 2.0 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
0.7 | 6.6 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.7 | 17.8 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.6 | 4.5 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.6 | 5.8 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.6 | 143.9 | GO:0010951 | negative regulation of endopeptidase activity(GO:0010951) |
0.6 | 3.9 | GO:0060605 | tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
0.6 | 1.9 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
0.6 | 4.5 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.6 | 38.4 | GO:0035383 | acyl-CoA metabolic process(GO:0006637) thioester metabolic process(GO:0035383) |
0.6 | 5.1 | GO:0015866 | ADP transport(GO:0015866) |
0.6 | 1.3 | GO:0002215 | defense response to nematode(GO:0002215) |
0.6 | 6.9 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.6 | 6.3 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
0.6 | 7.5 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.6 | 1.8 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.6 | 10.4 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.6 | 6.7 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
0.6 | 11.5 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.6 | 19.3 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.6 | 1.8 | GO:0060101 | negative regulation of phagocytosis, engulfment(GO:0060101) |
0.6 | 4.2 | GO:0006782 | protoporphyrinogen IX biosynthetic process(GO:0006782) |
0.6 | 7.2 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.6 | 26.9 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.6 | 5.3 | GO:0034285 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
0.6 | 1.8 | GO:0010841 | positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) |
0.6 | 6.4 | GO:0043032 | positive regulation of macrophage activation(GO:0043032) |
0.6 | 2.3 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.6 | 4.1 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) |
0.6 | 3.5 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
0.6 | 1.7 | GO:0030576 | Cajal body organization(GO:0030576) |
0.6 | 1.7 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.6 | 6.3 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.6 | 2.3 | GO:0070673 | response to interleukin-18(GO:0070673) |
0.6 | 5.7 | GO:0042747 | circadian sleep/wake cycle, REM sleep(GO:0042747) |
0.6 | 1.7 | GO:0002669 | positive regulation of T cell tolerance induction(GO:0002666) positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.6 | 2.2 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.6 | 2.8 | GO:0016321 | female meiosis chromosome segregation(GO:0016321) |
0.5 | 7.1 | GO:0019430 | removal of superoxide radicals(GO:0019430) |
0.5 | 6.0 | GO:0006026 | aminoglycan catabolic process(GO:0006026) glycosaminoglycan catabolic process(GO:0006027) |
0.5 | 2.2 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.5 | 1.6 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.5 | 3.7 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.5 | 1.1 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.5 | 6.4 | GO:0006956 | complement activation(GO:0006956) |
0.5 | 1.1 | GO:0072223 | metanephric glomerular mesangium development(GO:0072223) metanephric glomerular mesangial cell proliferation involved in metanephros development(GO:0072262) |
0.5 | 1.1 | GO:0070602 | regulation of centromeric sister chromatid cohesion(GO:0070602) |
0.5 | 2.7 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.5 | 7.9 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.5 | 1.6 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.5 | 1.6 | GO:0001705 | ectoderm formation(GO:0001705) ectodermal cell fate commitment(GO:0001712) |
0.5 | 7.6 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.5 | 5.1 | GO:0006783 | heme biosynthetic process(GO:0006783) |
0.5 | 3.0 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
0.5 | 6.5 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.5 | 3.0 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.5 | 2.0 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.5 | 5.4 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.5 | 2.9 | GO:0031120 | snRNA pseudouridine synthesis(GO:0031120) |
0.5 | 2.4 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.5 | 9.2 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.5 | 10.5 | GO:0017144 | drug metabolic process(GO:0017144) |
0.5 | 11.4 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.5 | 3.8 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.5 | 1.9 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.5 | 3.3 | GO:0006621 | protein retention in ER lumen(GO:0006621) |
0.5 | 0.9 | GO:0035928 | RNA import into mitochondrion(GO:0035927) rRNA import into mitochondrion(GO:0035928) |
0.5 | 1.8 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.5 | 3.7 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.5 | 12.4 | GO:0045214 | sarcomere organization(GO:0045214) |
0.5 | 14.9 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.5 | 5.4 | GO:0015825 | L-serine transport(GO:0015825) |
0.4 | 1.3 | GO:0071883 | receptor transactivation(GO:0035624) epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.4 | 1.3 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.4 | 0.9 | GO:0097156 | fasciculation of motor neuron axon(GO:0097156) |
0.4 | 3.1 | GO:0000022 | mitotic spindle elongation(GO:0000022) mitotic spindle midzone assembly(GO:0051256) |
0.4 | 0.9 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.4 | 12.5 | GO:0030261 | chromosome condensation(GO:0030261) |
0.4 | 1.3 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
0.4 | 7.2 | GO:0035404 | histone-serine phosphorylation(GO:0035404) |
0.4 | 5.9 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.4 | 0.8 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.4 | 2.1 | GO:0034552 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
0.4 | 4.2 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.4 | 1.2 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.4 | 3.7 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.4 | 4.1 | GO:0061734 | parkin-mediated mitophagy in response to mitochondrial depolarization(GO:0061734) |
0.4 | 4.9 | GO:0006544 | glycine metabolic process(GO:0006544) |
0.4 | 0.8 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.4 | 16.2 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.4 | 1.2 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.4 | 5.9 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.4 | 5.9 | GO:0072520 | seminiferous tubule development(GO:0072520) |
0.4 | 6.7 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.4 | 1.6 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.4 | 7.1 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.4 | 1.6 | GO:0060327 | cytoplasmic actin-based contraction involved in cell motility(GO:0060327) |
0.4 | 4.3 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.4 | 0.8 | GO:0052501 | killing by symbiont of host cells(GO:0001907) induction of programmed cell death(GO:0012502) disruption by symbiont of host cell(GO:0044004) modulation of programmed cell death in other organism(GO:0044531) modulation of apoptotic process in other organism(GO:0044532) positive regulation of apoptotic process in other organism(GO:0044533) modulation by symbiont of host programmed cell death(GO:0052040) positive regulation by symbiont of host programmed cell death(GO:0052042) modulation by symbiont of host apoptotic process(GO:0052150) positive regulation by symbiont of host apoptotic process(GO:0052151) modulation of programmed cell death in other organism involved in symbiotic interaction(GO:0052248) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) modulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052433) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) positive regulation of apoptotic process by virus(GO:0060139) |
0.4 | 1.9 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.4 | 1.1 | GO:0010037 | response to carbon dioxide(GO:0010037) |
0.4 | 2.3 | GO:0097264 | self proteolysis(GO:0097264) |
0.4 | 3.4 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.4 | 1.9 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.4 | 2.6 | GO:0072711 | cellular response to hydroxyurea(GO:0072711) |
0.4 | 1.9 | GO:0036017 | response to erythropoietin(GO:0036017) |
0.4 | 5.6 | GO:0048240 | sperm capacitation(GO:0048240) |
0.4 | 1.1 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
0.4 | 1.5 | GO:0044725 | chromatin reprogramming in the zygote(GO:0044725) |
0.4 | 3.3 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.4 | 1.1 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.4 | 1.5 | GO:2000427 | regulation of apoptotic cell clearance(GO:2000425) positive regulation of apoptotic cell clearance(GO:2000427) |
0.4 | 9.5 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.4 | 1.5 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.4 | 1.1 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.4 | 4.0 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.4 | 2.9 | GO:0034214 | protein hexamerization(GO:0034214) |
0.4 | 3.2 | GO:1903298 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) |
0.4 | 1.8 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.4 | 1.8 | GO:0051182 | coenzyme transport(GO:0051182) |
0.3 | 3.5 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.3 | 1.7 | GO:0044861 | protein transport into plasma membrane raft(GO:0044861) |
0.3 | 0.7 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.3 | 8.0 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.3 | 2.1 | GO:1900115 | extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.3 | 5.0 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.3 | 2.0 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.3 | 2.3 | GO:0071404 | cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
0.3 | 1.9 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.3 | 2.2 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.3 | 1.5 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
0.3 | 1.5 | GO:0090650 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
0.3 | 0.9 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
0.3 | 11.2 | GO:0055008 | cardiac muscle tissue morphogenesis(GO:0055008) |
0.3 | 3.0 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
0.3 | 2.7 | GO:0001973 | adenosine receptor signaling pathway(GO:0001973) |
0.3 | 1.8 | GO:0043383 | negative T cell selection(GO:0043383) |
0.3 | 4.8 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
0.3 | 7.1 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
0.3 | 2.9 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.3 | 3.8 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
0.3 | 3.2 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.3 | 2.3 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.3 | 2.9 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.3 | 2.0 | GO:0007406 | negative regulation of neuroblast proliferation(GO:0007406) |
0.3 | 0.3 | GO:0039533 | regulation of MDA-5 signaling pathway(GO:0039533) positive regulation of MDA-5 signaling pathway(GO:1900245) |
0.3 | 3.1 | GO:0010954 | positive regulation of protein processing(GO:0010954) positive regulation of protein maturation(GO:1903319) |
0.3 | 2.5 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.3 | 2.2 | GO:0002579 | positive regulation of antigen processing and presentation(GO:0002579) |
0.3 | 1.1 | GO:0021526 | medial motor column neuron differentiation(GO:0021526) |
0.3 | 3.5 | GO:0031424 | keratinization(GO:0031424) |
0.3 | 4.8 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.3 | 1.6 | GO:0036492 | regulation of translation in response to endoplasmic reticulum stress(GO:0036490) regulation of translation initiation in response to endoplasmic reticulum stress(GO:0036491) eiF2alpha phosphorylation in response to endoplasmic reticulum stress(GO:0036492) negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.3 | 2.9 | GO:0045063 | T-helper 1 cell differentiation(GO:0045063) |
0.3 | 3.4 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.3 | 3.2 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.3 | 1.8 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.3 | 3.4 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.3 | 1.0 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.3 | 2.9 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.3 | 1.3 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.3 | 2.8 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.3 | 1.8 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.3 | 1.8 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
0.3 | 0.8 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.3 | 1.0 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.3 | 2.0 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) |
0.3 | 1.5 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.3 | 0.8 | GO:0097327 | response to antineoplastic agent(GO:0097327) |
0.3 | 0.8 | GO:1901228 | positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
0.2 | 3.7 | GO:0021534 | cell proliferation in hindbrain(GO:0021534) cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
0.2 | 2.2 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.2 | 1.5 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.2 | 1.0 | GO:0032620 | interleukin-17 production(GO:0032620) |
0.2 | 2.4 | GO:2000018 | regulation of male gonad development(GO:2000018) |
0.2 | 7.7 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.2 | 307.9 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.2 | 1.4 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.2 | 3.3 | GO:0007567 | parturition(GO:0007567) |
0.2 | 3.7 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.2 | 0.5 | GO:1904925 | positive regulation of macromitophagy(GO:1901526) regulation of mitophagy in response to mitochondrial depolarization(GO:1904923) positive regulation of mitophagy in response to mitochondrial depolarization(GO:1904925) |
0.2 | 2.1 | GO:0045056 | transcytosis(GO:0045056) |
0.2 | 2.8 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.2 | 25.1 | GO:0007586 | digestion(GO:0007586) |
0.2 | 3.8 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.2 | 1.3 | GO:0019348 | dolichol metabolic process(GO:0019348) |
0.2 | 0.7 | GO:0072103 | glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
0.2 | 0.4 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.2 | 1.6 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
0.2 | 2.0 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.2 | 1.0 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.2 | 0.4 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.2 | 1.8 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.2 | 0.4 | GO:2001183 | negative regulation of interleukin-10 secretion(GO:2001180) negative regulation of interleukin-12 secretion(GO:2001183) |
0.2 | 2.4 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
0.2 | 1.4 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.2 | 1.9 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.2 | 1.0 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.2 | 1.7 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.2 | 1.9 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.2 | 1.3 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.2 | 1.3 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.2 | 2.8 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) |
0.2 | 2.0 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.2 | 1.2 | GO:0060631 | regulation of meiosis I(GO:0060631) |
0.2 | 19.8 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.2 | 0.2 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.2 | 1.5 | GO:0009566 | fertilization(GO:0009566) |
0.2 | 2.7 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.2 | 2.7 | GO:0042108 | positive regulation of cytokine biosynthetic process(GO:0042108) |
0.2 | 0.8 | GO:1904749 | regulation of protein localization to nucleolus(GO:1904749) |
0.2 | 1.0 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
0.2 | 1.3 | GO:0045820 | negative regulation of nucleotide catabolic process(GO:0030812) negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
0.2 | 2.6 | GO:0090022 | regulation of neutrophil chemotaxis(GO:0090022) |
0.2 | 0.2 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.2 | 2.5 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.2 | 4.9 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.1 | 0.4 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.1 | 0.9 | GO:0055094 | response to lipoprotein particle(GO:0055094) |
0.1 | 0.4 | GO:0016240 | autophagosome docking(GO:0016240) |
0.1 | 3.0 | GO:0036075 | endochondral ossification(GO:0001958) replacement ossification(GO:0036075) |
0.1 | 1.4 | GO:0044090 | positive regulation of vacuole organization(GO:0044090) |
0.1 | 0.7 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.1 | 0.8 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
0.1 | 0.8 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.1 | 0.8 | GO:0046884 | luteinizing hormone secretion(GO:0032275) follicle-stimulating hormone secretion(GO:0046884) |
0.1 | 0.8 | GO:0044598 | polyketide metabolic process(GO:0030638) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.1 | 1.1 | GO:0018377 | protein myristoylation(GO:0018377) |
0.1 | 3.7 | GO:0097421 | liver regeneration(GO:0097421) |
0.1 | 0.1 | GO:0002577 | regulation of antigen processing and presentation(GO:0002577) |
0.1 | 0.5 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.1 | 1.2 | GO:1904292 | regulation of ERAD pathway(GO:1904292) |
0.1 | 0.9 | GO:0050655 | dermatan sulfate proteoglycan metabolic process(GO:0050655) |
0.1 | 2.7 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.1 | 1.3 | GO:0033189 | response to vitamin A(GO:0033189) |
0.1 | 0.5 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.1 | 0.4 | GO:0050706 | positive regulation of interleukin-1 beta production(GO:0032731) positive regulation of interleukin-1 production(GO:0032732) regulation of interleukin-1 beta secretion(GO:0050706) positive regulation of interleukin-1 secretion(GO:0050716) positive regulation of interleukin-1 beta secretion(GO:0050718) |
0.1 | 3.4 | GO:0071806 | protein transmembrane transport(GO:0071806) |
0.1 | 0.5 | GO:0035973 | aggrephagy(GO:0035973) |
0.1 | 1.5 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.1 | 0.3 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.1 | 0.5 | GO:0019516 | lactate oxidation(GO:0019516) |
0.1 | 1.6 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.1 | 2.9 | GO:2000036 | regulation of stem cell population maintenance(GO:2000036) |
0.1 | 1.2 | GO:0002478 | antigen processing and presentation of exogenous peptide antigen(GO:0002478) |
0.1 | 0.9 | GO:0034312 | diol biosynthetic process(GO:0034312) |
0.1 | 0.8 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.1 | 1.3 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.1 | 1.2 | GO:0051013 | microtubule severing(GO:0051013) |
0.1 | 0.4 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.1 | 2.2 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.1 | 0.8 | GO:0043457 | regulation of cellular respiration(GO:0043457) |
0.1 | 0.6 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.1 | 0.8 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.1 | 1.2 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
0.1 | 2.0 | GO:0007520 | myoblast fusion(GO:0007520) |
0.1 | 1.0 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.1 | 5.3 | GO:0006096 | glycolytic process(GO:0006096) |
0.1 | 0.2 | GO:0071600 | otic vesicle development(GO:0071599) otic vesicle morphogenesis(GO:0071600) |
0.1 | 0.4 | GO:0051661 | maintenance of centrosome location(GO:0051661) maintenance of Golgi location(GO:0051684) |
0.1 | 0.8 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.1 | 0.9 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
0.1 | 0.6 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.1 | 0.6 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.1 | 4.0 | GO:0001824 | blastocyst development(GO:0001824) |
0.1 | 3.1 | GO:0048645 | organ formation(GO:0048645) |
0.1 | 0.2 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
0.1 | 0.6 | GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
0.1 | 0.3 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.1 | 1.4 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.1 | 0.3 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.1 | 3.8 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.1 | 1.3 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
0.1 | 0.9 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.1 | 2.4 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.1 | 1.6 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.1 | 1.5 | GO:0060325 | face morphogenesis(GO:0060325) |
0.1 | 0.4 | GO:0048840 | otolith development(GO:0048840) |
0.1 | 1.5 | GO:0097186 | amelogenesis(GO:0097186) |
0.1 | 0.3 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.1 | 0.7 | GO:0002183 | cytoplasmic translational initiation(GO:0002183) |
0.1 | 1.7 | GO:0009410 | response to xenobiotic stimulus(GO:0009410) |
0.1 | 0.6 | GO:0051601 | exocyst localization(GO:0051601) |
0.1 | 0.4 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.1 | 0.6 | GO:0006337 | nucleosome disassembly(GO:0006337) |
0.1 | 0.7 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.1 | 0.1 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.1 | 0.1 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
0.1 | 0.4 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
0.1 | 0.7 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.0 | 0.2 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.0 | 1.9 | GO:0014902 | myotube differentiation(GO:0014902) |
0.0 | 2.1 | GO:0007338 | single fertilization(GO:0007338) |
0.0 | 1.5 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
0.0 | 0.7 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.0 | 1.2 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.0 | 0.1 | GO:1990164 | histone H2A phosphorylation(GO:1990164) |
0.0 | 0.1 | GO:1900095 | random inactivation of X chromosome(GO:0060816) regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.0 | 0.3 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
0.0 | 0.4 | GO:1990118 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.0 | 0.0 | GO:0009644 | response to high light intensity(GO:0009644) |
0.0 | 0.2 | GO:0007530 | sex determination(GO:0007530) |
0.0 | 0.2 | GO:0033692 | cellular polysaccharide biosynthetic process(GO:0033692) |
0.0 | 0.2 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) |
0.0 | 0.7 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.0 | 2.8 | GO:0090501 | RNA phosphodiester bond hydrolysis(GO:0090501) |
0.0 | 0.5 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
0.0 | 0.1 | GO:0070084 | protein initiator methionine removal(GO:0070084) |
0.0 | 0.4 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.0 | 6.8 | GO:0007283 | spermatogenesis(GO:0007283) |
0.0 | 0.7 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.0 | 0.2 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.0 | 0.8 | GO:0006672 | ceramide metabolic process(GO:0006672) |
0.0 | 0.0 | GO:0036265 | RNA (guanine-N7)-methylation(GO:0036265) |
0.0 | 0.1 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.0 | 0.0 | GO:1903721 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
0.0 | 0.1 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.0 | 0.1 | GO:0035082 | axoneme assembly(GO:0035082) |
0.0 | 0.8 | GO:1903749 | positive regulation of establishment of protein localization to mitochondrion(GO:1903749) positive regulation of protein targeting to mitochondrion(GO:1903955) |
0.0 | 0.3 | GO:0051782 | negative regulation of cell division(GO:0051782) |
0.0 | 0.0 | GO:1903960 | negative regulation of anion channel activity(GO:0010360) negative regulation of anion transmembrane transport(GO:1903960) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
9.3 | 65.4 | GO:0005579 | membrane attack complex(GO:0005579) |
7.9 | 63.2 | GO:0005577 | fibrinogen complex(GO:0005577) |
3.9 | 15.4 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
3.7 | 58.8 | GO:0042612 | MHC class I protein complex(GO:0042612) |
3.2 | 12.9 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
3.1 | 12.4 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
2.7 | 18.9 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
2.5 | 12.7 | GO:1990716 | axonemal central apparatus(GO:1990716) |
2.5 | 10.1 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
2.2 | 8.9 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
2.2 | 37.6 | GO:0044217 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
2.2 | 6.5 | GO:0070821 | tertiary granule membrane(GO:0070821) |
2.2 | 19.5 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
2.1 | 39.7 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
2.1 | 231.3 | GO:0072562 | blood microparticle(GO:0072562) |
2.0 | 20.3 | GO:0045179 | apical cortex(GO:0045179) |
1.9 | 56.8 | GO:0042588 | zymogen granule(GO:0042588) |
1.8 | 25.5 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
1.8 | 25.2 | GO:0032982 | myosin filament(GO:0032982) |
1.8 | 23.2 | GO:0046581 | intercellular canaliculus(GO:0046581) |
1.8 | 8.9 | GO:0035061 | interchromatin granule(GO:0035061) |
1.8 | 8.8 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
1.7 | 5.2 | GO:0031680 | G-protein beta/gamma-subunit complex(GO:0031680) |
1.7 | 6.8 | GO:0019814 | immunoglobulin complex(GO:0019814) B cell receptor complex(GO:0019815) |
1.7 | 6.7 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
1.7 | 6.7 | GO:0001405 | presequence translocase-associated import motor(GO:0001405) |
1.6 | 20.2 | GO:0000801 | central element(GO:0000801) |
1.5 | 10.8 | GO:0090543 | Flemming body(GO:0090543) |
1.5 | 4.6 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
1.5 | 9.1 | GO:0036128 | CatSper complex(GO:0036128) |
1.3 | 4.0 | GO:0097124 | cyclin A2-CDK2 complex(GO:0097124) |
1.3 | 9.3 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
1.3 | 3.8 | GO:0032807 | DNA ligase IV complex(GO:0032807) |
1.3 | 8.8 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
1.2 | 8.7 | GO:0005833 | hemoglobin complex(GO:0005833) |
1.2 | 8.4 | GO:0097524 | sperm plasma membrane(GO:0097524) |
1.2 | 3.6 | GO:0045257 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) fumarate reductase complex(GO:0045283) |
1.1 | 4.6 | GO:0031436 | BRCA1-BARD1 complex(GO:0031436) |
1.1 | 3.4 | GO:0042627 | chylomicron(GO:0042627) |
1.1 | 7.9 | GO:0044194 | cytolytic granule(GO:0044194) |
1.1 | 6.5 | GO:0097209 | epidermal lamellar body(GO:0097209) |
1.1 | 5.4 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
1.0 | 17.4 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.9 | 14.1 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.9 | 1.9 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.9 | 8.1 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.9 | 8.7 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.8 | 3.3 | GO:0097413 | Lewy body(GO:0097413) |
0.8 | 19.7 | GO:0097225 | sperm midpiece(GO:0097225) |
0.8 | 8.9 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.8 | 6.3 | GO:0002177 | manchette(GO:0002177) |
0.8 | 10.2 | GO:0042599 | lamellar body(GO:0042599) |
0.8 | 12.5 | GO:0031672 | A band(GO:0031672) |
0.8 | 4.6 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.7 | 18.7 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.7 | 2.8 | GO:0030478 | actin cap(GO:0030478) |
0.7 | 2.1 | GO:1990589 | ATF4-CREB1 transcription factor complex(GO:1990589) |
0.7 | 2.0 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.7 | 13.9 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.7 | 11.2 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.7 | 4.0 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.7 | 44.7 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.6 | 2.6 | GO:0002947 | tumor necrosis factor receptor superfamily complex(GO:0002947) |
0.6 | 4.5 | GO:0051286 | cell tip(GO:0051286) |
0.6 | 1.9 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
0.6 | 3.8 | GO:0060205 | cytoplasmic membrane-bounded vesicle lumen(GO:0060205) |
0.6 | 15.7 | GO:0001533 | cornified envelope(GO:0001533) |
0.6 | 11.2 | GO:0005916 | fascia adherens(GO:0005916) |
0.6 | 12.9 | GO:0031528 | microvillus membrane(GO:0031528) |
0.6 | 2.4 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.6 | 6.7 | GO:0045180 | basal cortex(GO:0045180) |
0.6 | 1.8 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.6 | 2.3 | GO:0044299 | C-fiber(GO:0044299) |
0.6 | 4.1 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.6 | 1.7 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
0.6 | 1.1 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.6 | 2.3 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.6 | 7.2 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.5 | 6.6 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.5 | 5.5 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.5 | 16.5 | GO:0005771 | multivesicular body(GO:0005771) |
0.5 | 2.6 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.5 | 3.7 | GO:0070449 | elongin complex(GO:0070449) |
0.5 | 9.6 | GO:0033391 | chromatoid body(GO:0033391) |
0.5 | 1.5 | GO:0097125 | cyclin B1-CDK1 complex(GO:0097125) |
0.5 | 2.0 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.5 | 4.4 | GO:0032059 | bleb(GO:0032059) |
0.5 | 1.5 | GO:0032437 | cuticular plate(GO:0032437) |
0.5 | 4.4 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.5 | 4.3 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.5 | 1.9 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.5 | 1.4 | GO:0033165 | interphotoreceptor matrix(GO:0033165) |
0.5 | 1.4 | GO:0030690 | Noc1p-Noc2p complex(GO:0030690) |
0.4 | 4.0 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.4 | 2.2 | GO:0043203 | axon hillock(GO:0043203) |
0.4 | 2.6 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.4 | 3.9 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.4 | 4.4 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
0.4 | 2.2 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.4 | 7.6 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.4 | 2.0 | GO:0005642 | annulate lamellae(GO:0005642) |
0.4 | 1.2 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.4 | 1.6 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.4 | 2.3 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.4 | 1.1 | GO:0098835 | presynaptic endocytic zone(GO:0098833) presynaptic endocytic zone membrane(GO:0098835) |
0.4 | 1.5 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.4 | 24.6 | GO:0005811 | lipid particle(GO:0005811) |
0.4 | 2.5 | GO:0097452 | GAIT complex(GO:0097452) |
0.4 | 1.4 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.3 | 40.8 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.3 | 455.8 | GO:0005615 | extracellular space(GO:0005615) |
0.3 | 2.1 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.3 | 4.7 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.3 | 6.7 | GO:0005922 | connexon complex(GO:0005922) |
0.3 | 2.9 | GO:0031429 | box H/ACA snoRNP complex(GO:0031429) box H/ACA RNP complex(GO:0072588) |
0.3 | 0.6 | GO:0035692 | macrophage migration inhibitory factor receptor complex(GO:0035692) |
0.3 | 87.5 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.3 | 1.6 | GO:0097361 | CIA complex(GO:0097361) |
0.3 | 1.6 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.3 | 8.9 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.3 | 39.2 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.3 | 26.2 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.3 | 5.8 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.3 | 2.8 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) |
0.3 | 1.1 | GO:0097342 | death-inducing signaling complex(GO:0031264) ripoptosome(GO:0097342) |
0.3 | 13.5 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.3 | 1.6 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
0.3 | 5.7 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.3 | 6.6 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.2 | 1.5 | GO:0001940 | male pronucleus(GO:0001940) |
0.2 | 2.0 | GO:0000974 | Prp19 complex(GO:0000974) |
0.2 | 14.1 | GO:0045178 | basal part of cell(GO:0045178) |
0.2 | 1.2 | GO:0043256 | laminin complex(GO:0043256) |
0.2 | 3.0 | GO:0070852 | cell body fiber(GO:0070852) |
0.2 | 1.8 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.2 | 1.8 | GO:0005921 | gap junction(GO:0005921) |
0.2 | 1.6 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.2 | 4.9 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.2 | 0.9 | GO:0031417 | NatC complex(GO:0031417) |
0.2 | 1.7 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.2 | 0.8 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.2 | 13.2 | GO:0045095 | keratin filament(GO:0045095) |
0.2 | 2.5 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.2 | 1.9 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.2 | 0.7 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.2 | 3.7 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.2 | 18.8 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.2 | 0.9 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.2 | 8.1 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.2 | 2.3 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.2 | 23.2 | GO:0031674 | I band(GO:0031674) |
0.2 | 6.4 | GO:0005902 | microvillus(GO:0005902) |
0.2 | 2.3 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.2 | 0.8 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
0.2 | 1.1 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 7.9 | GO:0005643 | nuclear pore(GO:0005643) |
0.1 | 0.8 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.1 | 1.5 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.1 | 2.4 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 0.7 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.1 | 1.3 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.1 | 2.3 | GO:0005839 | proteasome core complex(GO:0005839) |
0.1 | 0.9 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.1 | 1.0 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 2.0 | GO:0030663 | COPI-coated vesicle membrane(GO:0030663) |
0.1 | 1.5 | GO:0016580 | Sin3 complex(GO:0016580) |
0.1 | 1.2 | GO:0016010 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.1 | 1.0 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.1 | 0.9 | GO:0034464 | BBSome(GO:0034464) |
0.1 | 3.1 | GO:0016459 | myosin complex(GO:0016459) |
0.1 | 71.5 | GO:0042175 | nuclear outer membrane-endoplasmic reticulum membrane network(GO:0042175) |
0.1 | 4.6 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.1 | 3.2 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.1 | 0.5 | GO:0060091 | kinocilium(GO:0060091) |
0.1 | 0.3 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
0.1 | 1.3 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.1 | 2.4 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.1 | 3.1 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 0.7 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.1 | 3.9 | GO:0015030 | Cajal body(GO:0015030) |
0.1 | 2.9 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.1 | 0.5 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 1.1 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 1.9 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.1 | 14.3 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 3.7 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.1 | 0.6 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 0.8 | GO:0005865 | striated muscle thin filament(GO:0005865) myofilament(GO:0036379) |
0.1 | 1.9 | GO:0005844 | polysome(GO:0005844) |
0.1 | 61.7 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 3.2 | GO:0032587 | ruffle membrane(GO:0032587) |
0.1 | 0.1 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.0 | 0.9 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.0 | 0.6 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 1.6 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 0.4 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.0 | 0.3 | GO:0016600 | flotillin complex(GO:0016600) |
0.0 | 0.7 | GO:0019028 | viral capsid(GO:0019028) |
0.0 | 1.0 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.0 | 0.6 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.0 | 0.3 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 0.2 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.0 | 0.1 | GO:0071821 | FANCM-MHF complex(GO:0071821) |
0.0 | 0.8 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.0 | 1.1 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 0.2 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
11.8 | 59.0 | GO:0005550 | pheromone binding(GO:0005550) |
10.0 | 30.0 | GO:0098603 | selenol Se-methyltransferase activity(GO:0098603) |
6.5 | 19.4 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
6.4 | 38.6 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
6.2 | 18.6 | GO:0004478 | methionine adenosyltransferase activity(GO:0004478) |
5.4 | 32.3 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
5.2 | 31.0 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
5.1 | 20.4 | GO:0030294 | receptor signaling protein tyrosine kinase inhibitor activity(GO:0030294) |
4.8 | 24.2 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
4.7 | 23.4 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
4.6 | 18.6 | GO:0004771 | sterol esterase activity(GO:0004771) |
4.5 | 18.0 | GO:0004967 | glucagon receptor activity(GO:0004967) |
4.4 | 13.1 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
4.4 | 17.4 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
4.3 | 12.9 | GO:0030172 | troponin C binding(GO:0030172) |
4.3 | 29.8 | GO:0035375 | zymogen binding(GO:0035375) |
4.1 | 12.4 | GO:0031720 | haptoglobin binding(GO:0031720) |
4.0 | 31.9 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
4.0 | 15.9 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
4.0 | 11.9 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
3.9 | 11.8 | GO:0003844 | 1,4-alpha-glucan branching enzyme activity(GO:0003844) |
3.9 | 15.4 | GO:0019002 | GMP binding(GO:0019002) |
3.7 | 11.2 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
3.7 | 11.0 | GO:0001847 | opsonin receptor activity(GO:0001847) |
3.7 | 11.0 | GO:0071885 | N-terminal protein N-methyltransferase activity(GO:0071885) |
3.6 | 10.9 | GO:0004655 | porphobilinogen synthase activity(GO:0004655) |
3.6 | 14.2 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
3.5 | 17.3 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
3.4 | 13.6 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
3.3 | 13.3 | GO:0042806 | fucose binding(GO:0042806) |
3.3 | 16.4 | GO:0019770 | IgG receptor activity(GO:0019770) |
3.2 | 13.0 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
3.2 | 12.8 | GO:0034618 | arginine binding(GO:0034618) |
3.2 | 9.6 | GO:0052871 | leukotriene-B4 20-monooxygenase activity(GO:0050051) tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) |
3.0 | 18.1 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
3.0 | 9.0 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
3.0 | 86.8 | GO:0008392 | arachidonic acid epoxygenase activity(GO:0008392) |
2.9 | 8.8 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
2.9 | 20.5 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
2.9 | 11.7 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
2.8 | 22.4 | GO:0051525 | NFAT protein binding(GO:0051525) |
2.8 | 44.7 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
2.8 | 30.7 | GO:0001846 | opsonin binding(GO:0001846) |
2.7 | 19.2 | GO:0016803 | ether hydrolase activity(GO:0016803) |
2.6 | 10.6 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
2.6 | 7.7 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
2.5 | 7.5 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
2.5 | 7.4 | GO:0046980 | peptide antigen-transporting ATPase activity(GO:0015433) tapasin binding(GO:0046980) |
2.5 | 7.4 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
2.4 | 9.6 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
2.3 | 14.1 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
2.3 | 16.2 | GO:0048019 | receptor antagonist activity(GO:0048019) |
2.3 | 70.7 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
2.2 | 6.6 | GO:0046977 | TAP binding(GO:0046977) TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
2.2 | 8.7 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) |
2.1 | 6.4 | GO:0032810 | sterol response element binding(GO:0032810) |
2.1 | 8.4 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
2.1 | 8.3 | GO:0004064 | arylesterase activity(GO:0004064) |
2.0 | 8.1 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
2.0 | 6.0 | GO:0004370 | glycerol kinase activity(GO:0004370) |
2.0 | 8.0 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
2.0 | 8.0 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
2.0 | 9.9 | GO:0004103 | choline kinase activity(GO:0004103) |
1.9 | 7.7 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
1.9 | 11.5 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
1.9 | 5.8 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
1.9 | 5.6 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
1.9 | 14.8 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
1.8 | 5.5 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
1.8 | 5.5 | GO:0036468 | aromatic-L-amino-acid decarboxylase activity(GO:0004058) L-dopa decarboxylase activity(GO:0036468) |
1.8 | 209.1 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
1.8 | 10.5 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
1.7 | 22.6 | GO:0003796 | lysozyme activity(GO:0003796) |
1.7 | 17.3 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
1.7 | 1.7 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
1.7 | 5.1 | GO:0004021 | L-alanine:2-oxoglutarate aminotransferase activity(GO:0004021) alanine-oxo-acid transaminase activity(GO:0047635) |
1.7 | 8.4 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
1.6 | 8.2 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
1.6 | 6.5 | GO:0046790 | virion binding(GO:0046790) |
1.6 | 4.8 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
1.6 | 6.2 | GO:0035514 | DNA demethylase activity(GO:0035514) oxidative RNA demethylase activity(GO:0035515) |
1.5 | 4.6 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
1.5 | 6.1 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
1.5 | 4.5 | GO:0001605 | adrenomedullin receptor activity(GO:0001605) |
1.5 | 14.7 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
1.4 | 4.3 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
1.4 | 14.1 | GO:0019957 | C-C chemokine binding(GO:0019957) |
1.4 | 4.2 | GO:0002058 | uracil binding(GO:0002058) pyrimidine nucleobase binding(GO:0002061) dihydrouracil dehydrogenase (NAD+) activity(GO:0004159) dihydropyrimidine dehydrogenase (NADP+) activity(GO:0017113) |
1.4 | 8.4 | GO:0048039 | ubiquinone binding(GO:0048039) |
1.4 | 5.5 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
1.4 | 6.8 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
1.3 | 4.0 | GO:0004618 | phosphoglycerate kinase activity(GO:0004618) |
1.3 | 4.0 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
1.3 | 6.5 | GO:0034191 | apolipoprotein A-I receptor binding(GO:0034191) |
1.3 | 285.4 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
1.3 | 5.2 | GO:0055077 | gap junction hemi-channel activity(GO:0055077) |
1.3 | 5.1 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) cholestenone 5-alpha-reductase activity(GO:0047751) |
1.3 | 45.5 | GO:0004364 | glutathione transferase activity(GO:0004364) |
1.2 | 7.4 | GO:0055104 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
1.2 | 3.7 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
1.2 | 3.7 | GO:0015254 | glycerol channel activity(GO:0015254) |
1.2 | 3.6 | GO:0070976 | TIR domain binding(GO:0070976) |
1.2 | 3.6 | GO:0004946 | bombesin receptor activity(GO:0004946) |
1.2 | 10.8 | GO:0019864 | IgG binding(GO:0019864) |
1.2 | 3.6 | GO:0004104 | acetylcholinesterase activity(GO:0003990) cholinesterase activity(GO:0004104) |
1.2 | 34.7 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
1.2 | 5.9 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
1.2 | 3.5 | GO:0004825 | methionine-tRNA ligase activity(GO:0004825) |
1.2 | 17.3 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
1.1 | 4.6 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
1.1 | 42.1 | GO:0005044 | scavenger receptor activity(GO:0005044) |
1.1 | 32.6 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
1.1 | 5.6 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
1.1 | 3.3 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
1.1 | 3.2 | GO:0004775 | succinate-CoA ligase activity(GO:0004774) succinate-CoA ligase (ADP-forming) activity(GO:0004775) |
1.1 | 4.2 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
1.0 | 5.2 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
1.0 | 5.2 | GO:0004969 | histamine receptor activity(GO:0004969) |
1.0 | 2.1 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
1.0 | 15.4 | GO:0005523 | tropomyosin binding(GO:0005523) |
1.0 | 3.1 | GO:0048030 | disaccharide binding(GO:0048030) |
1.0 | 3.1 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
1.0 | 4.1 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
1.0 | 4.0 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
1.0 | 4.0 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
1.0 | 15.9 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
1.0 | 3.9 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
1.0 | 12.6 | GO:0016208 | AMP binding(GO:0016208) |
1.0 | 5.8 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
1.0 | 7.7 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
1.0 | 10.5 | GO:0004017 | adenylate kinase activity(GO:0004017) |
1.0 | 2.9 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
1.0 | 3.8 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.9 | 2.8 | GO:0019959 | interleukin-8 receptor activity(GO:0004918) interleukin-8 binding(GO:0019959) |
0.9 | 20.8 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.9 | 12.2 | GO:0097200 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.9 | 2.8 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.9 | 4.7 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.9 | 2.8 | GO:0003921 | GMP synthase activity(GO:0003921) GMP synthase (glutamine-hydrolyzing) activity(GO:0003922) |
0.9 | 4.6 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.9 | 6.4 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.9 | 12.6 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.9 | 7.2 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.9 | 2.7 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.9 | 9.8 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.9 | 2.7 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.9 | 10.5 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.9 | 3.4 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.9 | 1.7 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.8 | 17.8 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.8 | 2.5 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
0.8 | 7.5 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.8 | 4.1 | GO:0001155 | TFIIIA-class transcription factor binding(GO:0001155) |
0.8 | 7.4 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.8 | 4.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.8 | 21.7 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.8 | 1.6 | GO:0004051 | arachidonate 5-lipoxygenase activity(GO:0004051) |
0.8 | 11.9 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.8 | 1.6 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
0.8 | 3.2 | GO:0047619 | acylcarnitine hydrolase activity(GO:0047619) |
0.8 | 3.9 | GO:0031798 | type 1 metabotropic glutamate receptor binding(GO:0031798) |
0.8 | 5.5 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.8 | 9.4 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.8 | 7.0 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.8 | 6.9 | GO:0030957 | Tat protein binding(GO:0030957) |
0.7 | 3.7 | GO:0050733 | RS domain binding(GO:0050733) |
0.7 | 8.8 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.7 | 3.7 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.7 | 8.7 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.7 | 15.1 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.7 | 5.7 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.7 | 2.1 | GO:1990763 | arrestin family protein binding(GO:1990763) |
0.7 | 6.2 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.7 | 9.7 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.7 | 9.6 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.7 | 8.2 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.7 | 4.1 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.7 | 3.4 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.7 | 2.0 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.7 | 6.7 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.7 | 1.3 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.7 | 2.0 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.7 | 11.8 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.7 | 5.2 | GO:0016004 | phospholipase activator activity(GO:0016004) lipase activator activity(GO:0060229) |
0.6 | 10.9 | GO:0070628 | proteasome binding(GO:0070628) |
0.6 | 8.0 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.6 | 2.5 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.6 | 3.7 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.6 | 1.8 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.6 | 4.2 | GO:0015526 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.6 | 5.3 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.6 | 10.1 | GO:0008199 | ferric iron binding(GO:0008199) |
0.6 | 1.8 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.6 | 1.8 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
0.6 | 18.5 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.6 | 9.3 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.6 | 2.9 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.6 | 5.1 | GO:0015217 | ATP transmembrane transporter activity(GO:0005347) ADP transmembrane transporter activity(GO:0015217) |
0.6 | 3.9 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.6 | 4.4 | GO:0016421 | CoA carboxylase activity(GO:0016421) |
0.6 | 3.3 | GO:0004568 | chitinase activity(GO:0004568) |
0.5 | 4.9 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.5 | 8.1 | GO:0001618 | virus receptor activity(GO:0001618) |
0.5 | 1.6 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.5 | 11.7 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.5 | 3.2 | GO:0036374 | gamma-glutamyltransferase activity(GO:0003840) glutathione hydrolase activity(GO:0036374) |
0.5 | 1.6 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
0.5 | 1.6 | GO:0008281 | sulfonylurea receptor activity(GO:0008281) |
0.5 | 5.2 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.5 | 10.9 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.5 | 1.0 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.5 | 2.1 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.5 | 2.1 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.5 | 5.7 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.5 | 4.6 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.5 | 2.5 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
0.5 | 13.3 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.5 | 5.8 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.5 | 15.2 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.5 | 1.4 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
0.5 | 5.1 | GO:0017166 | vinculin binding(GO:0017166) |
0.5 | 2.3 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.5 | 3.2 | GO:0043559 | insulin binding(GO:0043559) |
0.5 | 5.5 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.5 | 1.4 | GO:0097677 | STAT family protein binding(GO:0097677) |
0.5 | 5.4 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.4 | 1.3 | GO:0032190 | acrosin binding(GO:0032190) |
0.4 | 2.2 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.4 | 1.7 | GO:0035473 | lipase binding(GO:0035473) |
0.4 | 3.5 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.4 | 2.1 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.4 | 13.1 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.4 | 10.9 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.4 | 111.6 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.4 | 2.5 | GO:0031404 | chloride ion binding(GO:0031404) |
0.4 | 1.7 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.4 | 1.2 | GO:0050567 | glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity(GO:0050567) |
0.4 | 4.4 | GO:0015643 | toxic substance binding(GO:0015643) |
0.4 | 3.9 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.4 | 8.6 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.4 | 11.2 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.4 | 2.3 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.4 | 1.9 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.4 | 6.1 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
0.4 | 2.9 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.4 | 7.3 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.4 | 1.1 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.4 | 8.7 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.4 | 10.8 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
0.4 | 3.2 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.4 | 1.4 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.3 | 1.0 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.3 | 2.8 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.3 | 2.7 | GO:0008494 | translation activator activity(GO:0008494) |
0.3 | 7.0 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.3 | 5.6 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.3 | 1.6 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.3 | 4.6 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.3 | 1.3 | GO:0004738 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
0.3 | 1.9 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.3 | 1.0 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
0.3 | 10.0 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.3 | 7.2 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.3 | 1.2 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.3 | 1.5 | GO:0047493 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.3 | 1.2 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.3 | 3.7 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.3 | 0.9 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
0.3 | 0.6 | GO:0004315 | 3-oxoacyl-[acyl-carrier-protein] synthase activity(GO:0004315) |
0.3 | 2.7 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.3 | 0.9 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.3 | 2.0 | GO:0045340 | mercury ion binding(GO:0045340) |
0.3 | 1.1 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
0.3 | 1.1 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.3 | 1.4 | GO:0043515 | kinetochore binding(GO:0043515) |
0.3 | 1.9 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) macromolecule transmembrane transporter activity(GO:0022884) |
0.3 | 1.9 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
0.3 | 0.8 | GO:0047025 | 3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity(GO:0047025) |
0.3 | 0.8 | GO:0046911 | metal chelating activity(GO:0046911) |
0.3 | 2.4 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.3 | 1.8 | GO:0016918 | retinal binding(GO:0016918) |
0.3 | 1.3 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.3 | 1.5 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.3 | 2.8 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.3 | 1.5 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.2 | 1.0 | GO:0050692 | DBD domain binding(GO:0050692) |
0.2 | 1.2 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.2 | 100.4 | GO:0005549 | odorant binding(GO:0005549) |
0.2 | 10.8 | GO:0005507 | copper ion binding(GO:0005507) |
0.2 | 4.8 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.2 | 14.1 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.2 | 2.1 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.2 | 207.5 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.2 | 0.9 | GO:0070052 | collagen V binding(GO:0070052) |
0.2 | 1.6 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.2 | 3.4 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.2 | 8.4 | GO:0003823 | antigen binding(GO:0003823) |
0.2 | 1.7 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.2 | 3.0 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
0.2 | 2.9 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.2 | 4.8 | GO:0016706 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors(GO:0016706) |
0.2 | 1.4 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.2 | 20.9 | GO:0015405 | primary active transmembrane transporter activity(GO:0015399) P-P-bond-hydrolysis-driven transmembrane transporter activity(GO:0015405) |
0.2 | 4.3 | GO:0004866 | endopeptidase inhibitor activity(GO:0004866) |
0.2 | 1.0 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.2 | 3.8 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.2 | 3.5 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.2 | 1.5 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.2 | 3.8 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.2 | 0.9 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.2 | 6.4 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.2 | 4.2 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.2 | 0.9 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.2 | 1.4 | GO:0008656 | cysteine-type endopeptidase activator activity involved in apoptotic process(GO:0008656) peptidase activator activity involved in apoptotic process(GO:0016505) |
0.2 | 1.5 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.2 | 4.6 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.2 | 2.5 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.2 | 1.3 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.2 | 40.6 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.2 | 5.2 | GO:0030332 | cyclin binding(GO:0030332) |
0.2 | 3.6 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.2 | 4.3 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.2 | 4.7 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.2 | 0.5 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.2 | 1.5 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.2 | 4.2 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.2 | 2.3 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.1 | 1.9 | GO:0016702 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
0.1 | 2.7 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.1 | 1.2 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.1 | 4.9 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.1 | 1.1 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 1.8 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.1 | 0.7 | GO:0019956 | chemokine binding(GO:0019956) |
0.1 | 0.7 | GO:0008061 | chitin binding(GO:0008061) |
0.1 | 1.2 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.1 | 4.1 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.1 | 0.9 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.6 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.1 | 1.3 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
0.1 | 0.9 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.1 | 2.6 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.1 | 2.2 | GO:0070300 | phosphatidic acid binding(GO:0070300) |
0.1 | 4.1 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.1 | 3.4 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.1 | 1.2 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 1.1 | GO:0044213 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.1 | 5.9 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.1 | 6.0 | GO:0051087 | chaperone binding(GO:0051087) |
0.1 | 0.7 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.1 | 0.3 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.1 | 1.8 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.1 | 1.7 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.1 | 1.6 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.1 | 1.4 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.1 | 3.7 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 11.3 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.7 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.1 | 2.1 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
0.1 | 1.5 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 4.5 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 0.7 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.1 | 0.6 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 0.4 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) diacylglycerol O-acyltransferase activity(GO:0004144) |
0.1 | 7.1 | GO:0052689 | carboxylic ester hydrolase activity(GO:0052689) |
0.1 | 1.5 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 0.5 | GO:0000182 | rDNA binding(GO:0000182) |
0.1 | 7.2 | GO:0001047 | core promoter binding(GO:0001047) |
0.1 | 0.2 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.1 | 0.9 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
0.1 | 0.7 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 0.3 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.0 | 0.2 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.0 | 0.4 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.0 | 0.1 | GO:0031386 | protein tag(GO:0031386) |
0.0 | 0.2 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.0 | 0.8 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.0 | 0.5 | GO:0030371 | translation repressor activity(GO:0030371) |
0.0 | 0.5 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.0 | 0.4 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.0 | 1.0 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
0.0 | 0.3 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
0.0 | 1.5 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.0 | 2.2 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.0 | 0.1 | GO:0070728 | leucine binding(GO:0070728) |
0.0 | 0.3 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.0 | 0.4 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.0 | 0.3 | GO:0015288 | porin activity(GO:0015288) |
0.0 | 0.1 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.0 | 0.8 | GO:0004540 | ribonuclease activity(GO:0004540) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.7 | 29.9 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
2.5 | 77.3 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
1.4 | 6.9 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
1.3 | 13.5 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
1.2 | 64.0 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
1.2 | 280.9 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.9 | 32.4 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.7 | 21.0 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.7 | 9.9 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.6 | 23.9 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.6 | 9.8 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.6 | 6.6 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.6 | 19.3 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.6 | 6.6 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.5 | 5.2 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.5 | 10.7 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.5 | 21.8 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.4 | 12.8 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.4 | 6.0 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.4 | 7.3 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.4 | 7.9 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.4 | 9.8 | ST ADRENERGIC | Adrenergic Pathway |
0.4 | 4.1 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.3 | 9.5 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.3 | 15.6 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.3 | 4.9 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.3 | 8.0 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.3 | 2.5 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.3 | 14.3 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.3 | 3.8 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.3 | 2.7 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.3 | 9.3 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.3 | 3.6 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.3 | 2.5 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.2 | 37.8 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.2 | 2.5 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.2 | 48.5 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.2 | 7.8 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.2 | 7.6 | PID BCR 5PATHWAY | BCR signaling pathway |
0.2 | 3.8 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.2 | 2.8 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.2 | 1.2 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.2 | 5.6 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.2 | 10.4 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.2 | 7.8 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.2 | 6.2 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.2 | 18.5 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.2 | 0.8 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.2 | 2.2 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.2 | 1.5 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.2 | 1.8 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.1 | 1.9 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.1 | 0.7 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 2.0 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 1.7 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.1 | 6.8 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.1 | 4.7 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 3.6 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.1 | 4.1 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.1 | 3.8 | PID SHP2 PATHWAY | SHP2 signaling |
0.1 | 1.3 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 0.5 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 0.9 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.1 | 4.6 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 0.4 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.1 | 0.8 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.1 | 0.7 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.1 | 1.0 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.1 | 1.7 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.1 | 3.6 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.1 | 2.5 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 0.7 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 1.3 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 0.7 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.5 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.0 | 1.7 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 1.4 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 0.3 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.2 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.0 | 0.3 | PID BARD1 PATHWAY | BARD1 signaling events |
0.0 | 0.7 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.7 | 75.4 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
4.0 | 111.2 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
3.9 | 50.9 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
3.6 | 10.9 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
3.4 | 71.3 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
2.9 | 14.6 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
2.9 | 55.0 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
2.6 | 38.4 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
2.4 | 21.7 | REACTOME INTERFERON SIGNALING | Genes involved in Interferon Signaling |
2.4 | 40.7 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
2.4 | 21.2 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
2.2 | 39.2 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
1.7 | 107.9 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
1.7 | 49.6 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
1.6 | 22.4 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
1.4 | 7.2 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
1.4 | 53.9 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
1.3 | 4.0 | REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6 | Genes involved in CDK-mediated phosphorylation and removal of Cdc6 |
1.3 | 11.7 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
1.3 | 62.5 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
1.3 | 18.9 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
1.2 | 9.9 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
1.2 | 20.0 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
1.1 | 5.7 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
1.1 | 16.3 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GIP | Genes involved in Synthesis, Secretion, and Inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP) |
1.1 | 15.0 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
1.0 | 2.1 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
1.0 | 47.4 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.9 | 7.5 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.9 | 10.9 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.9 | 13.2 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.9 | 11.4 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.9 | 12.8 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.7 | 6.6 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.7 | 1.4 | REACTOME PHOSPHORYLATION OF THE APC C | Genes involved in Phosphorylation of the APC/C |
0.6 | 8.2 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.6 | 7.2 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.6 | 8.7 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.6 | 6.6 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.5 | 10.7 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.5 | 5.2 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.5 | 4.1 | REACTOME OPSINS | Genes involved in Opsins |
0.5 | 6.2 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.5 | 9.9 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.5 | 7.9 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.4 | 5.4 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.4 | 15.6 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.4 | 4.9 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.4 | 3.9 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.4 | 1.7 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.4 | 3.9 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.4 | 73.8 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.4 | 17.0 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.4 | 5.6 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.4 | 4.0 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.4 | 6.2 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.4 | 6.1 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.4 | 6.7 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.4 | 2.6 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.4 | 7.1 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.4 | 4.2 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.4 | 2.1 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
0.4 | 6.7 | REACTOME SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE | Genes involved in Synthesis of PIPs at the Golgi membrane |
0.3 | 7.6 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.3 | 3.8 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.3 | 9.7 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.3 | 3.7 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.3 | 18.8 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.3 | 11.5 | REACTOME GLUCOSE METABOLISM | Genes involved in Glucose metabolism |
0.3 | 10.6 | REACTOME IL RECEPTOR SHC SIGNALING | Genes involved in Interleukin receptor SHC signaling |
0.3 | 25.8 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.3 | 1.8 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.3 | 2.8 | REACTOME RAF MAP KINASE CASCADE | Genes involved in RAF/MAP kinase cascade |
0.2 | 7.6 | REACTOME KINESINS | Genes involved in Kinesins |
0.2 | 10.7 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.2 | 1.1 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.2 | 0.9 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.2 | 2.8 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.2 | 1.5 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.2 | 9.3 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.2 | 3.0 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.2 | 2.3 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
0.2 | 4.0 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.2 | 3.6 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.2 | 12.2 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.2 | 2.3 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.2 | 1.2 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.2 | 2.3 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.2 | 4.4 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.2 | 1.5 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.2 | 4.1 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.2 | 5.8 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 3.1 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.1 | 10.0 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.1 | 0.5 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.1 | 14.2 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
0.1 | 3.0 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 3.0 | REACTOME TRNA AMINOACYLATION | Genes involved in tRNA Aminoacylation |
0.1 | 4.6 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 0.5 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.1 | 2.5 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.1 | 2.4 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 1.7 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 2.8 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.1 | 1.5 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 1.3 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.1 | 2.3 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.1 | 2.8 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.1 | 1.1 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.1 | 1.1 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.1 | 1.6 | REACTOME PI METABOLISM | Genes involved in PI Metabolism |
0.1 | 0.5 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 0.7 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.1 | 0.2 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.1 | 9.1 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 1.0 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.0 | 0.5 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.0 | 0.4 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.0 | 0.3 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |